false--12-31Q2201910-Q00015875230000000600000600000000000000.010.014000000004000000009021277991115305000.010.01100000001000000000 0001587523 2019-01-01 2019-06-30 0001587523 2019-07-26 0001587523 2018-04-01 2018-06-30 0001587523 2018-01-01 2018-06-30 0001587523 2019-04-01 2019-06-30 0001587523 2019-06-30 0001587523 2018-12-31 0001587523 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001587523 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0001587523 us-gaap:CommonStockMember 2019-06-30 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001587523 us-gaap:CommonStockMember 2018-12-31 0001587523 us-gaap:RetainedEarningsMember 2019-06-30 0001587523 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001587523 us-gaap:RetainedEarningsMember 2018-12-31 0001587523 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001587523 2017-12-31 0001587523 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001587523 us-gaap:RetainedEarningsMember 2018-06-30 0001587523 us-gaap:CommonStockMember 2018-06-30 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001587523 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001587523 us-gaap:CommonStockMember 2017-12-31 0001587523 2018-06-30 0001587523 us-gaap:RetainedEarningsMember 2017-12-31 0001587523 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001587523 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0001587523 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001587523 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001587523 2019-03-31 0001587523 us-gaap:RetainedEarningsMember 2019-03-31 0001587523 us-gaap:CommonStockMember 2019-03-31 0001587523 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0001587523 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001587523 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001587523 2018-03-31 0001587523 us-gaap:RetainedEarningsMember 2018-03-31 0001587523 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001587523 us-gaap:CommonStockMember 2018-03-31 0001587523 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001587523 us-gaap:InventoryValuationReserveMember 2019-04-01 2019-06-30 0001587523 2019-01-01 2019-03-31 0001587523 us-gaap:NonrecurringAdjustmentDomain 2018-04-01 2018-06-30 0001587523 us-gaap:InventoryValuationReserveMember 2018-01-01 2018-03-31 0001587523 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2018-01-01 2018-06-30 0001587523 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2018-04-01 2018-06-30 0001587523 kn:TimingDeviceBusinessMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember kn:PrecisionDevicesMember 2018-01-01 2018-12-31 0001587523 kn:TimingDeviceBusinessMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember kn:PrecisionDevicesMember 2018-01-01 2018-12-31 0001587523 kn:TimingDeviceBusinessMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember kn:PrecisionDevicesMember 2017-11-28 0001587523 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2019-01-01 2019-06-30 0001587523 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2019-06-30 0001587523 us-gaap:AccountsPayableMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2019-04-01 2019-06-30 0001587523 us-gaap:AccountsPayableMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2018-01-01 2018-06-30 0001587523 us-gaap:AccountsPayableMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2018-04-01 2018-06-30 0001587523 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2019-04-01 2019-06-30 0001587523 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2018-12-31 0001587523 us-gaap:AccountsPayableMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2019-01-01 2019-06-30 0001587523 kn:CompexCorporationMember 2018-01-19 2018-01-19 0001587523 kn:A17Q1CapacitorAcquisitionMember 2017-01-11 2017-01-11 0001587523 kn:A17Q1CapacitorAcquisitionMember 2017-01-01 2017-12-31 0001587523 kn:A17Q1CapacitorAcquisitionMember us-gaap:ScenarioForecastMember 2017-04-01 2019-12-31 0001587523 kn:CompexCorporationMember 2018-01-19 2018-06-30 0001587523 kn:DITFInterconnectTechnologyInc.Member us-gaap:CustomerRelationshipsMember 2019-01-03 2019-01-03 0001587523 kn:DITFInterconnectTechnologyInc.Member 2019-01-03 2019-01-03 0001587523 kn:CompexCorporationMember 2018-01-19 2018-03-31 0001587523 kn:A17Q1CapacitorAcquisitionMember 2018-01-01 2018-09-30 0001587523 kn:DITFInterconnectTechnologyInc.Member 2019-01-03 0001587523 us-gaap:OtherLiabilitiesMember kn:CompexCorporationMember 2018-01-19 2018-01-19 0001587523 kn:DITFInterconnectTechnologyInc.Member us-gaap:UnpatentedTechnologyMember 2019-01-03 2019-01-03 0001587523 kn:DITFInterconnectTechnologyInc.Member 2019-01-03 2019-06-30 0001587523 kn:DITFInterconnectTechnologyInc.Member us-gaap:TrademarksMember 2019-01-03 2019-01-03 0001587523 kn:DITFInterconnectTechnologyInc.Member us-gaap:TrademarksMember 2019-01-03 0001587523 kn:DITFInterconnectTechnologyInc.Member us-gaap:CustomerRelationshipsMember 2019-01-03 0001587523 kn:DITFInterconnectTechnologyInc.Member us-gaap:UnpatentedTechnologyMember 2019-01-03 0001587523 us-gaap:EquipmentMember 2019-06-30 0001587523 us-gaap:LandMember 2019-06-30 0001587523 us-gaap:BuildingAndBuildingImprovementsMember 2018-12-31 0001587523 us-gaap:LandMember 2018-12-31 0001587523 us-gaap:EquipmentMember 2018-12-31 0001587523 us-gaap:BuildingAndBuildingImprovementsMember 2019-06-30 0001587523 kn:PrecisionDevicesMember 2018-12-31 0001587523 kn:PrecisionDevicesMember 2019-06-30 0001587523 kn:AudioMember 2018-12-31 0001587523 kn:PrecisionDevicesMember 2019-01-01 2019-06-30 0001587523 kn:AudioMember 2019-06-30 0001587523 kn:AudioMember 2019-01-01 2019-06-30 0001587523 us-gaap:CustomerRelationshipsMember 2018-12-31 0001587523 us-gaap:PatentsMember 2018-12-31 0001587523 us-gaap:OtherIntangibleAssetsMember 2018-12-31 0001587523 us-gaap:TrademarksMember 2018-12-31 0001587523 us-gaap:CustomerRelationshipsMember 2019-06-30 0001587523 us-gaap:UnpatentedTechnologyMember 2018-12-31 0001587523 us-gaap:UnpatentedTechnologyMember 2019-06-30 0001587523 us-gaap:PatentsMember 2019-06-30 0001587523 us-gaap:TrademarksMember 2019-06-30 0001587523 us-gaap:OtherIntangibleAssetsMember 2019-06-30 0001587523 us-gaap:TrademarksMember 2018-12-31 0001587523 us-gaap:TrademarksMember 2019-06-30 0001587523 srt:MinimumMember 2019-01-01 2019-06-30 0001587523 srt:MaximumMember 2019-06-30 0001587523 srt:MinimumMember 2019-06-30 0001587523 us-gaap:RestructuringChargesMember kn:EmployeeSeveranceandFacilityClosingMember 2018-04-01 2018-06-30 0001587523 us-gaap:OperatingExpenseMember kn:EmployeeSeveranceandFacilityClosingMember 2019-01-01 2019-06-30 0001587523 kn:CostofGoodsSoldRestructuringChargesMember kn:EmployeeSeveranceandFacilityClosingMember 2018-01-01 2018-06-30 0001587523 kn:CostofGoodsSoldRestructuringChargesMember kn:EmployeeSeveranceandFacilityClosingMember 2019-04-01 2019-06-30 0001587523 kn:CostofGoodsSoldRestructuringChargesMember kn:EmployeeSeveranceandFacilityClosingMember 2019-01-01 2019-06-30 0001587523 us-gaap:FacilityClosingMember 2019-01-01 2019-01-01 0001587523 us-gaap:RestructuringChargesMember kn:EmployeeSeveranceandFacilityClosingMember 2018-01-01 2018-06-30 0001587523 us-gaap:OperatingExpenseMember kn:EmployeeSeveranceandFacilityClosingMember 2019-04-01 2019-06-30 0001587523 us-gaap:CorporateNonSegmentMember kn:EmployeeSeveranceandFacilityClosingMember 2018-04-01 2018-06-30 0001587523 kn:EmployeeSeveranceandFacilityClosingMember 2019-01-01 2019-06-30 0001587523 us-gaap:CorporateNonSegmentMember kn:EmployeeSeveranceandFacilityClosingMember 2019-04-01 2019-06-30 0001587523 kn:EmployeeSeveranceandFacilityClosingMember 2018-01-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:EmployeeSeveranceandFacilityClosingMember kn:AudioMember 2018-04-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:EmployeeSeveranceandFacilityClosingMember kn:AudioMember 2019-04-01 2019-06-30 0001587523 us-gaap:CorporateNonSegmentMember kn:EmployeeSeveranceandFacilityClosingMember 2019-01-01 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:EmployeeSeveranceandFacilityClosingMember kn:PrecisionDevicesMember 2018-01-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:EmployeeSeveranceandFacilityClosingMember kn:PrecisionDevicesMember 2019-04-01 2019-06-30 0001587523 kn:EmployeeSeveranceandFacilityClosingMember 2019-04-01 2019-06-30 0001587523 kn:EmployeeSeveranceandFacilityClosingMember 2018-04-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:EmployeeSeveranceandFacilityClosingMember kn:AudioMember 2019-01-01 2019-06-30 0001587523 us-gaap:CorporateNonSegmentMember kn:EmployeeSeveranceandFacilityClosingMember 2018-01-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:EmployeeSeveranceandFacilityClosingMember kn:AudioMember 2018-01-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:EmployeeSeveranceandFacilityClosingMember kn:PrecisionDevicesMember 2018-04-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:EmployeeSeveranceandFacilityClosingMember kn:PrecisionDevicesMember 2019-01-01 2019-06-30 0001587523 kn:OtherAccruedExpensesMember 2018-12-31 0001587523 kn:OtherAccruedExpensesMember 2019-06-30 0001587523 us-gaap:OtherLiabilitiesMember 2019-06-30 0001587523 us-gaap:OtherLiabilitiesMember 2018-12-31 0001587523 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-06-30 0001587523 us-gaap:FacilityClosingMember 2019-01-01 2019-06-30 0001587523 us-gaap:FacilityClosingMember 2019-06-30 0001587523 us-gaap:EmployeeSeveranceMember 2018-12-31 0001587523 us-gaap:FacilityClosingMember 2018-12-31 0001587523 us-gaap:EmployeeSeveranceMember 2019-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-01-01 2018-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2019-01-01 2019-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-01-01 2018-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-01-01 2018-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-06-30 0001587523 kn:OtherAccruedExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001587523 kn:OtherAccruedExpensesMember kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember 2019-06-30 0001587523 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001587523 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember 2019-06-30 0001587523 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember 2018-12-31 0001587523 kn:OtherAccruedExpensesMember kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember 2018-12-31 0001587523 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001587523 kn:OtherAccruedExpensesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001587523 us-gaap:InterestRateSwapMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-04-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-04-01 2018-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-04-01 2019-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-04-01 2018-06-30 0001587523 us-gaap:ForeignCurrencyGainLossMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember 2018-12-31 0001587523 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-06-30 0001587523 us-gaap:ForeignCurrencyGainLossMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0001587523 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-04-01 2018-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-04-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-04-01 2018-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-04-01 2018-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-04-01 2019-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-04-01 2018-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2018-04-01 2018-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-04-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-04-01 2019-06-30 0001587523 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001587523 kn:ForeignCurrencyEconomicHedgeMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2019-04-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-04-01 2019-06-30 0001587523 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-04-01 2018-06-30 0001587523 kn:ConvertibleNotesDueTwentyTwentyOneMember us-gaap:ConvertibleDebtMember 2019-06-30 0001587523 kn:CreditFacilitydueOctober112022Member us-gaap:LineOfCreditMember 2018-12-31 0001587523 kn:ConvertibleNotesDueTwentyTwentyOneMember us-gaap:ConvertibleDebtMember 2018-12-31 0001587523 kn:CreditFacilitydueOctober112022Member us-gaap:LineOfCreditMember 2019-06-30 0001587523 kn:ConvertibleNotesDueTwentyTwentyOneMember us-gaap:ConvertibleDebtMember 2019-01-01 2019-06-30 0001587523 kn:ConvertibleNotesDueTwentyTwentyOneMember us-gaap:ConvertibleDebtMember 2018-04-01 2018-06-30 0001587523 kn:ConvertibleNotesDueTwentyTwentyOneMember us-gaap:ConvertibleDebtMember 2018-01-01 2018-06-30 0001587523 kn:ConvertibleNotesDueTwentyTwentyOneMember us-gaap:ConvertibleDebtMember 2019-04-01 2019-06-30 0001587523 kn:ConvertibleNotesDueTwentyTwentyOneMember us-gaap:ConvertibleDebtMember 2016-05-04 0001587523 srt:MaximumMember kn:CreditFacilitydueOctober112022Member 2019-01-01 2019-06-30 0001587523 kn:ConvertibleNotesDueTwentyTwentyOneMember us-gaap:ConvertibleDebtMember 2016-04-01 2016-06-30 0001587523 srt:WeightedAverageMember us-gaap:LineOfCreditMember 2019-01-01 2019-06-30 0001587523 srt:WeightedAverageMember us-gaap:LineOfCreditMember 2018-01-01 2018-06-30 0001587523 srt:WeightedAverageMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-06-30 0001587523 srt:WeightedAverageMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-06-30 0001587523 kn:CreditFacilitydueOctober112022Member 2019-06-30 0001587523 srt:MinimumMember kn:CreditFacilitydueOctober112022Member us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-06-30 0001587523 srt:MinimumMember kn:CreditFacilitydueOctober112022Member 2019-01-01 2019-06-30 0001587523 srt:MaximumMember kn:CreditFacilitydueOctober112022Member us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-06-30 0001587523 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-06-30 0001587523 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-06-30 0001587523 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001587523 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 0001587523 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-06-30 0001587523 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-12-31 0001587523 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-06-30 0001587523 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001587523 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-06-30 0001587523 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001587523 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-06-30 0001587523 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-06-30 0001587523 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0001587523 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001587523 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0001587523 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-06-30 0001587523 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001587523 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-06-30 0001587523 us-gaap:ForeignCountryMember 2019-04-01 2019-06-30 0001587523 us-gaap:ForeignCountryMember 2018-04-01 2018-06-30 0001587523 us-gaap:ForeignCountryMember 2018-01-01 2018-06-30 0001587523 us-gaap:ForeignCountryMember 2019-01-01 2019-06-30 0001587523 us-gaap:EmployeeStockOptionMember 2018-12-31 0001587523 us-gaap:StockAppreciationRightsSARSMember 2019-01-01 2019-06-30 0001587523 us-gaap:EmployeeStockOptionMember 2019-06-30 0001587523 us-gaap:StockAppreciationRightsSARSMember 2019-06-30 0001587523 us-gaap:StockAppreciationRightsSARSMember 2018-12-31 0001587523 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001587523 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001587523 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001587523 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001587523 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001587523 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001587523 us-gaap:PerformanceSharesMember 2019-06-30 0001587523 us-gaap:PerformanceSharesMember 2018-12-31 0001587523 us-gaap:PerformanceSharesMember 2019-01-01 2019-06-30 0001587523 us-gaap:RestrictedStockUnitsRSUMember 2019-06-30 0001587523 srt:MaximumMember us-gaap:PerformanceSharesMember 2019-01-01 2019-06-30 0001587523 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-06-30 0001587523 srt:MinimumMember us-gaap:PerformanceSharesMember 2019-01-01 2019-06-30 0001587523 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001587523 country:US 2018-01-01 2018-06-30 0001587523 srt:EuropeMember 2018-04-01 2018-06-30 0001587523 kn:OtherGeographicalLocationsMember 2018-01-01 2018-06-30 0001587523 kn:OtherAmericasMember 2018-04-01 2018-06-30 0001587523 srt:EuropeMember 2019-04-01 2019-06-30 0001587523 kn:OtherAmericasMember 2019-04-01 2019-06-30 0001587523 srt:EuropeMember 2018-01-01 2018-06-30 0001587523 kn:OtherAmericasMember 2019-01-01 2019-06-30 0001587523 country:US 2018-04-01 2018-06-30 0001587523 country:US 2019-01-01 2019-06-30 0001587523 kn:OtherGeographicalLocationsMember 2018-04-01 2018-06-30 0001587523 kn:OtherGeographicalLocationsMember 2019-01-01 2019-06-30 0001587523 srt:AsiaMember 2018-04-01 2018-06-30 0001587523 srt:EuropeMember 2019-01-01 2019-06-30 0001587523 kn:OtherGeographicalLocationsMember 2019-04-01 2019-06-30 0001587523 country:US 2019-04-01 2019-06-30 0001587523 srt:AsiaMember 2018-01-01 2018-06-30 0001587523 srt:AsiaMember 2019-01-01 2019-06-30 0001587523 kn:OtherAmericasMember 2018-01-01 2018-06-30 0001587523 srt:AsiaMember 2019-04-01 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:AudioMember 2019-06-30 0001587523 us-gaap:CorporateNonSegmentMember 2018-12-31 0001587523 us-gaap:OperatingSegmentsMember kn:PrecisionDevicesMember 2018-12-31 0001587523 us-gaap:OperatingSegmentsMember kn:AudioMember 2018-12-31 0001587523 us-gaap:CorporateNonSegmentMember 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:PrecisionDevicesMember 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:PrecisionDevicesMember 2019-01-01 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:PrecisionDevicesMember 2019-04-01 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:AudioMember 2018-04-01 2018-06-30 0001587523 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-06-30 0001587523 us-gaap:CorporateNonSegmentMember 2019-04-01 2019-06-30 0001587523 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:AudioMember 2019-04-01 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:AudioMember 2018-01-01 2018-06-30 0001587523 us-gaap:CorporateNonSegmentMember 2018-04-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:AudioMember 2019-01-01 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:PrecisionDevicesMember 2018-04-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember kn:PrecisionDevicesMember 2018-01-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0001587523 us-gaap:OperatingSegmentsMember 2018-04-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember 2018-01-01 2018-06-30 0001587523 us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares kn:segments
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q

(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019.

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the transition period from to


Commission File Number: 001-36102

Knowles Corporation
(Exact name of registrant as specified in its charter)

Delaware
90-1002689
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)

1511 Maplewood Drive, Itasca, IL
(Address of Principal Executive Offices)


60143
(Zip Code)

(630) 250-5100
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading symbol
 
Name of each exchange on which registered
Common stock, $0.01 par value per share
 
KN
 
New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes   No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes   No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
 
Accelerated filer
Non-accelerated filer
 
Small reporting company
 
 
 
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes   No  

The number of shares outstanding of the registrant’s common stock as of July 26, 2019 was 91,115,382.




Knowles Corporation
Form 10-Q
Table of Contents

 
 
Page
1
1
 
1
 
2
 
3
 
4
 
6
 
7
28
29
45
45
 
 
 
45
45
45
46
47
48



Table of Contents


PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

KNOWLES CORPORATION
CONSOLIDATED STATEMENTS OF EARNINGS
(in millions, except share and per share amounts)
(unaudited)

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Revenues
$
205.2


$
188.4

 
$
385.0

 
$
366.9

Cost of goods sold
128.4

 
115.1

 
239.2

 
228.3

Restructuring charges - cost of goods sold
0.4

 
0.1

 
0.9

 
0.1

Gross profit
76.4

 
73.2

 
144.9

 
138.5

Research and development expenses
25.0

 
25.4

 
49.7

 
50.2

Selling and administrative expenses
38.9

 
37.1

 
76.5

 
72.9

Restructuring charges
0.1

 
0.5

 
1.9

 
0.9

Operating expenses
64.0

 
63.0

 
128.1

 
124.0

Operating earnings
12.4

 
10.2

 
16.8

 
14.5

Interest expense, net
3.6

 
4.1

 
7.1

 
8.1

Other (income) expense, net
(0.5
)
 
0.3

 
0.5

 
0.2

Earnings before income taxes and discontinued operations
9.3

 
5.8

 
9.2

 
6.2

Provision for income taxes
3.4

 
1.4

 
6.0

 
2.2

Earnings from continuing operations
5.9

 
4.4

 
3.2

 
4.0

Earnings from discontinued operations, net

 
0.2

 

 
0.3

Net earnings
$
5.9

 
$
4.6

 
$
3.2


$
4.3

 
 
 
 
 
 
 
 
Earnings per share from continuing operations:
 
 
 
 
 
 
 
Basic
$
0.06


$
0.05

 
$
0.04


$
0.04

Diluted
$
0.06

 
$
0.05

 
$
0.03

 
$
0.04

 
 
 
 
 
 
 
 
Earnings per share from discontinued operations:
 
 
 
 
 
 
 
Basic
$

 
$

 
$

 
$
0.01

Diluted
$

 
$

 
$

 
$
0.01

 
 
 
 
 
 
 
 
Net earnings per share:
 
 
 
 
 
 
 
Basic
$
0.06

 
$
0.05

 
$
0.04

 
$
0.05

Diluted
$
0.06

 
$
0.05

 
$
0.03

 
$
0.05

 
 
 
 
 
 
 
 
Weighted-average common shares outstanding:
 
 
 
 
 
 
 
Basic
91,018,213

 
90,063,089

 
90,780,035


89,893,557

Diluted
92,507,279

 
90,731,760

 
92,184,274


90,718,298



See accompanying Notes to Consolidated Financial Statements


1

Table of Contents


KNOWLES CORPORATION 
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS
(in millions)
(unaudited)

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Net earnings
$
5.9

 
$
4.6

 
$
3.2

 
$
4.3

 
 
 
 
 
 
 
 
Other comprehensive (loss) earnings, net of tax
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation
(2.5
)
 
(7.6
)
 
1.5

 
(2.7
)
 
 
 
 
 
 
 
 
Employee benefit plans:
 
 
 
 
 
 
 
Amortization or settlement of actuarial losses and prior service costs
0.2

 
0.2

 
0.3

 
0.3

Net change in employee benefit plans
0.2

 
0.2

 
0.3

 
0.3

 
 
 
 
 
 
 
 
Changes in fair value of cash flow hedges:
 
 
 
 
 
 
 
Unrealized net (losses) gains arising during period
(0.4
)
 
(2.0
)
 
0.2

 
(1.2
)
Net (gains) losses reclassified into earnings

 
(0.1
)
 
0.1

 
(0.7
)
Total cash flow hedges
(0.4
)
 
(2.1
)
 
0.3

 
(1.9
)
 
 
 
 
 
 
 
 
Other comprehensive (loss) earnings, net of tax
(2.7
)
 
(9.5
)
 
2.1

 
(4.3
)
 
 
 
 
 
 
 
 
Comprehensive earnings (loss)
$
3.2

 
$
(4.9
)
 
$
5.3

 
$


See accompanying Notes to Consolidated Financial Statements


2

Table of Contents


KNOWLES CORPORATION
CONSOLIDATED BALANCE SHEETS
(in millions, except share and per share amounts)
(unaudited)

 
June 30, 2019
 
December 31, 2018
Current assets:
 
 
 
Cash and cash equivalents
$
53.6

 
$
73.5

Receivables, net of allowance of $0.6
135.8

 
140.3

Inventories, net
159.7

 
140.1

Prepaid and other current assets
13.8

 
11.1

Total current assets
362.9

 
365.0

Property, plant, and equipment, net
211.9

 
211.7

Goodwill
891.1

 
887.9

Intangible assets, net
56.6

 
56.7

Operating lease right-of-use assets
38.1

 

Other assets and deferred charges
25.2

 
26.6

Total assets
$
1,585.8

 
$
1,547.9

 
 
 
 
Current liabilities:
 

 
 

Accounts payable
$
65.2

 
$
77.2

Accrued compensation and employee benefits
28.9

 
40.2

Operating lease liabilities
9.1

 

Other accrued expenses
19.7

 
20.1

Federal and other taxes on income
4.6

 
4.3

Total current liabilities
127.5

 
141.8

Long-term debt
171.9

 
158.1

Deferred income taxes
2.1

 
2.1

Long-term operating lease liabilities
29.4

 

Other liabilities
27.7

 
34.3

Commitments and contingencies (Note 16)


 


Stockholders' equity:
 
 
 
Preferred stock - $0.01 par value; 10,000,000 shares authorized; none issued

 

Common stock - $0.01 par value; 400,000,000 shares authorized; 91,115,305 and 90,212,779 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively
0.9

 
0.9

Additional paid-in capital
1,556.2

 
1,545.9

Accumulated deficit
(221.0
)
 
(224.2
)
Accumulated other comprehensive loss
(108.9
)
 
(111.0
)
Total stockholders' equity
1,227.2

 
1,211.6

Total liabilities and stockholders' equity
$
1,585.8

 
$
1,547.9


See accompanying Notes to Consolidated Financial Statements


3

Table of Contents


KNOWLES CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in millions)
(unaudited)

 
Common Stock
 
Additional Paid-In Capital
 
Accumulated Deficit
 
Accumulated Other Comprehensive Loss
 
Total Stockholders' Equity
Balance at March 31, 2019
$
0.9

 
$
1,548.7

 
$
(226.9
)
 
$
(106.2
)
 
$
1,216.5

Net earnings

 

 
5.9

 

 
5.9

Other comprehensive loss, net of tax

 

 

 
(2.7
)
 
(2.7
)
Stock-based compensation expense

 
7.3

 

 

 
7.3

Common stock issued for exercise of stock options and other

 
0.9

 

 

 
0.9

Tax on restricted stock unit vesting

 
(0.7
)
 

 

 
(0.7
)
Balance at June 30, 2019
$
0.9

 
$
1,556.2

 
$
(221.0
)
 
$
(108.9
)
 
$
1,227.2


 
Common Stock
 
Additional Paid-In Capital
 
Accumulated Deficit
 
Accumulated Other Comprehensive Loss
 
Total Stockholders' Equity
Balance at March 31, 2018
$
0.9

 
$
1,526.9

 
$
(292.2
)
 
$
(94.8
)
 
$
1,140.8

Net earnings

 

 
4.6

 

 
4.6

Other comprehensive loss, net of tax

 

 

 
(9.5
)
 
(9.5
)
Stock-based compensation expense

 
7.3

 

 

 
7.3

Common stock issued for exercise of stock options

 
0.1

 

 

 
0.1

Tax on restricted stock unit vesting

 
(0.7
)
 

 

 
(0.7
)
Balance at June 30, 2018
$
0.9

 
$
1,533.6

 
$
(287.6
)
 
$
(104.3
)
 
$
1,142.6


 
See accompanying Notes to Consolidated Financial Statements

4

Table of Contents


KNOWLES CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in millions)
(unaudited)

 
Common Stock
 
Additional Paid-In Capital
 
Accumulated Deficit
 
Accumulated Other Comprehensive Loss
 
Total Stockholders' Equity
Balance at December 31, 2018
$
0.9

 
$
1,545.9

 
$
(224.2
)
 
$
(111.0
)
 
$
1,211.6

Net earnings

 

 
3.2

 

 
3.2

Other comprehensive earnings, net of tax

 

 

 
2.1

 
2.1

Stock-based compensation expense

 
14.0

 

 

 
14.0

Common stock issued for exercise of stock options and other

 
1.8

 

 

 
1.8

Tax on restricted stock unit vesting

 
(5.5
)
 

 

 
(5.5
)
Balance at June 30, 2019
$
0.9

 
$
1,556.2

 
$
(221.0
)
 
$
(108.9
)
 
$
1,227.2


 
Common Stock
 
Additional Paid-In Capital
 
Accumulated Deficit
 
Accumulated Other Comprehensive Loss
 
Total Stockholders' Equity
Balance at December 31, 2017
$
0.9

 
$
1,523.1

 
$
(291.9
)
 
$
(100.0
)
 
$
1,132.1

Net earnings

 

 
4.3

 

 
4.3

Other comprehensive loss, net of tax

 

 

 
(4.3
)
 
(4.3
)
Stock-based compensation expense

 
14.3

 

 

 
14.3

Common stock issued for exercise of stock options

 
0.3

 

 

 
0.3

Tax on restricted stock unit vesting

 
(4.1
)
 

 

 
(4.1
)
Balance at June 30, 2018
$
0.9

 
$
1,533.6

 
$
(287.6
)
 
$
(104.3
)
 
$
1,142.6


 
See accompanying Notes to Consolidated Financial Statements


5

Table of Contents


KNOWLES CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
 
Six Months Ended June 30,
 
2019
 
2018
Operating Activities
 
 
 
Net earnings
$
3.2

 
$
4.3

Adjustments to reconcile net earnings to cash from operating activities:
 
 
 
Depreciation and amortization
27.0

 
26.6

Stock-based compensation
14.0

 
14.3

Non-cash interest expense and amortization of debt issuance costs
4.1

 
3.8

Loss on disposal of fixed assets

 
0.2

Deferred income taxes
(0.7
)
 
(2.8
)
Other, net
1.1

 
(0.3
)
Changes in assets and liabilities (excluding effects of foreign exchange):
 
 
 
Receivables, net
5.7

 
10.4

Inventories, net
(17.7
)
 
(33.9
)
Prepaid and other current assets
(3.0
)
 
(3.7
)
Accounts payable
(9.1
)
 
5.3

Accrued compensation and employee benefits
(11.2
)
 
(2.6
)
Other accrued expenses
1.0

 
(8.6
)
Accrued taxes
0.8

 
(6.0
)
Other non-current assets and non-current liabilities
(4.3
)
 
2.3

Net cash provided by operating activities
10.9

 
9.3

 
 
 
 
Investing Activities
 

 
 

Additions to property, plant, and equipment
(24.5
)
 
(48.0
)
Acquisitions of business (net of cash acquired)
(11.4
)
 
(17.5
)
Net cash used in investing activities
(35.9
)
 
(65.5
)
 
 
 
 
Financing Activities
 

 
 

Borrowings under revolving credit facility
10.0

 

Tax on restricted stock unit vesting
(5.5
)
 
(4.1
)
Payments of finance lease obligations
(0.9
)
 
(0.9
)
Payment of consideration owed for acquisitions
(0.2
)
 
(0.2
)
Net proceeds from exercise of stock-based awards
1.6

 
0.3

Net cash provided by (used in) financing activities
5.0

 
(4.9
)
 
 
 
 
Effect of exchange rate changes on cash and cash equivalents
0.1

 
0.2

 
 
 
 
Net decrease in cash and cash equivalents
(19.9
)
 
(60.9
)
Cash and cash equivalents at beginning of period
73.5

 
111.7

Cash and cash equivalents at end of period
$
53.6

 
$
50.8

 
 
 
 
Supplemental information - cash paid for:
 
 
 
Income taxes
$
6.9

 
$
6.9

Interest
$
3.8

 
$
4.1


See accompanying Notes to Consolidated Financial Statements


6


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 


1. Basis of Presentation

Description of Business - Knowles Corporation (NYSE:KN) is a market leader and global provider of advanced micro-acoustic, audio processing, and precision device solutions, serving the mobile consumer electronics, communications, medical, defense, automotive, and industrial markets. The Company uses its leading position in micro-electro-mechanical systems ("MEMS") microphones and strong capabilities in audio processing technologies to optimize audio systems and improve the user experience in mobile, ear, and Internet of Things ("IoT") applications. Knowles is also a leader in acoustic components, high-end capacitors, and mmWave radio frequency solutions for a diverse set of markets. The Company's focus on its customers, combined with its unique technology, proprietary manufacturing techniques, rigorous testing, and global scale, enable the Company to deliver innovative solutions that optimize the user experience. References to "Knowles," "the Company," "we," "our," and "us" refer to Knowles Corporation and its consolidated subsidiaries.

Financial Statement Presentation - The accompanying unaudited interim Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for quarterly reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. generally accepted accounting principles (“GAAP” or “U.S. GAAP”) for complete financial statements. These unaudited interim Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the year ended December 31, 2018 included in the Company’s Annual Report on Form 10-K.

The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. The unaudited interim Consolidated Financial Statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair statement of results for these interim periods.

During the second quarter of 2019, the Company recorded a correcting entry of $0.5 million related to inventory reserves, which decreased earnings before income taxes and discontinued operations. During the first quarter of 2019, the Company recorded a correcting entry of $0.4 million related to income taxes, which increased tax expense and decreased net earnings. These items are not material to the Consolidated Financial Statements for the historical periods in which the errors originated and are not expected to be material to the Consolidated Financial Statements for the year ended December 31, 2019. Similarly, and as disclosed in the prior year during the second quarter of 2018, the Company recorded a correcting entry of $1.3 million related to pre-spin-off pension obligations, which decreased earnings before income taxes and discontinued operations. During the first quarter of 2018, the Company recorded a correcting entry of $0.7 million related to inventory reserves, which increased earnings before income taxes and discontinued operations. These items were determined not to be material to the Consolidated Financial Statements for the historical periods in which the errors originated and the Consolidated Financial Statements for the year ended December 31, 2018.

On January 3, 2019, the Company acquired substantially all of the assets of DITF Interconnect Technology, Inc. ("DITF"), a thin film components manufacturer. See Note 4. Acquisitions for additional information related to the transaction.

Non-cash Investing Activities - Purchases of property, plant, and equipment included in accounts payable at June 30, 2019 and 2018 were $3.1 million and $5.9 million, respectively. These non-cash amounts are not reflected as outflows to Additions to property, plant, and equipment within investing activities of the Consolidated Statements of Cash Flows for the respective periods.

2. Recent Accounting Standards

Recently Issued Accounting Standards

In August 2018, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2018-14 to amend disclosure requirements related to defined benefit pension and other postretirement plans. The standard is effective for public business entities for fiscal years ending after December 15, 2020. Early adoption is permitted and retrospective application of the guidance is required. The Company has not yet determined the impact of the standard on its disclosures or its adoption date.


7


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

Recently Adopted Accounting Standards

In February 2018, the FASB issued ASU 2018-02, which allows the reclassification from accumulated other comprehensive income to retained earnings of stranded tax effects resulting from the Tax Reform Act. The standard also requires certain disclosures concerning stranded tax effects regardless of the election with respect to stranded tax effects resulting from the Tax Reform Act. The standard should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effects of the Tax Reform Act were recognized. The Company elected to reclassify the stranded tax effects resulting from the Tax Reform Act upon adoption of the standard on January 1, 2019. The impact of the reclassification from accumulated other comprehensive loss to accumulated deficit was less than $0.1 million. The Company's policy is to release income tax effects from accumulated other comprehensive loss in the period the underlying item expires.

In February 2016, the FASB issued ASU 2016-02 and issued subsequent amendments to the initial guidance within ASU 2018-01, ASU 2018-10, ASU 2018-11, ASU 2018-20, and ASU 2019-01, which are collectively referred to as Accounting Standards Codification ("ASC") 842. This guidance requires a lessee to recognize a lease liability and right-of-use asset for all leases, including operating leases, with a term greater than 12 months. The Company adopted the standard as of January 1, 2019 under the prospective transition method that did not require comparative period financial statements to be adjusted. See Note 8. Leases for additional information. Periods prior to January 1, 2019 have been presented in accordance with prior guidance (ASC 840). The Company elected the transition package of practical expedients for leases that commenced before the adoption date, which among other things, allowed the Company to carry forward historical lease classifications. The Company also elected the practical expedient to not separate nonlease components from lease components, which increased lease liabilities and right-of-use assets through the inclusion of fixed payments for nonlease components such as maintenance.

The Company assessed its lease portfolio as of the adoption date as well as implemented accounting processes and enhanced internal controls for the continued maintenance of the lease portfolio under the new standard. The Company recognized approximately $40 million of operating lease liabilities and right-of-use assets on its Consolidated Balance Sheets as of January 1, 2019. Finance leases were not impacted by the adoption of ASC 842 as finance lease liabilities and right-of-use assets were recognized on the Consolidated Balance Sheets for periods prior to January 1, 2019 under ASC 840. The standard did not materially impact the Consolidated Statements of Earnings or Consolidated Statements of Cash Flows.

3. Disposed and Discontinued Operations

Management and the Board of Directors periodically conduct strategic reviews of the Company's businesses.

On November 28, 2017, the Company completed the sale of its high-end oscillators business ("Timing Device Business"), part of the Precision Devices ("PD") segment, for $130.0 million, plus purchase price adjustments for a net amount of $135.1 million. The Company recorded a gain of $63.9 million as a result of the sale, which included $0.4 million of gain amounts reclassified from Accumulated other comprehensive loss into earnings related to currency translation adjustments. The purchase price included $10.0 million held in escrow that was received during the third quarter of 2018.

In accordance with ASC 205-20, Presentation of Financial Statements - Discontinued Operations, the results of operations and financial position of the Timing Device Business have been reclassified to discontinued operations for all periods presented as the disposal represents a strategic shift that had a major effect on the Company's results of operations.


8


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

Summarized results of the Company's discontinued operations are as follows:
(in millions)
Three Months Ended June 30, 2018
 
Six Months Ended June 30, 2018
Revenues
$

 
$

Cost of goods sold

 

Gross profit

 

Selling and administrative expenses
(0.2
)
 
(0.2
)
Operating income
(0.2
)
 
(0.2
)
Other income, net

 
(0.2
)
Earnings from discontinued operations before taxes (1)
0.2

 
0.4

Provision for income taxes

 
0.1

Earnings from discontinued operations, net of tax
$
0.2

 
$
0.3

(1) The Company's policy is to not allocate interest expense to discontinued operations unless it is directly attributable to the operations. The results of operations of the Timing Device Business did not have any such interest expense in the periods presented.

Discontinued operations had no impact on the Company's results of operations for the three and six months ended June 30, 2019. There were no assets and liabilities of discontinued operations as of June 30, 2019 and December 31, 2018. There was no depreciation, amortization of intangible assets, or capital expenditures related to discontinued operations during the six months ended June 30, 2019 and 2018.

4. Acquisitions

DITF Acquisition

On January 3, 2019, the Company acquired substantially all of the assets of DITF for $11.1 million. The acquired business provides thin film components to the defense, telecommunication, industrial, and medical markets. The transaction was accounted for under the acquisition method of accounting and the results of operations are included in the Consolidated Financial Statements from the date of acquisition in the PD segment. Included in the Consolidated Statements of Earnings are DITF's revenues and loss before income taxes of $4.0 million and $0.2 million, respectively, from the date of acquisition through June 30, 2019.

The table below represents a preliminary allocation of the purchase price to net assets acquired as of January 3, 2019:
(in millions)
Receivables
$
1.2

Inventories
0.9

Property, plant, and equipment
2.8

Customer relationships
1.4

Unpatented technologies
1.3

Trademarks and other amortized intangible assets
0.7

Other assets
0.5

Goodwill
3.2

Assumed liabilities
(0.9
)
Total purchase price
$
11.1



Customer relationships, unpatented technologies, and trademarks will be amortized over estimated useful lives of 6 years, 6 years, and 7 years, respectively. The fair value for customer relationships was determined using the excess earnings method under the income approach. The fair values of unpatented technologies and trademarks were determined using the relief from royalty method under the income approach. The fair value measurements of intangible assets are based on significant unobservable inputs, and thus represent Level 3 inputs. Significant assumptions used in assessing the fair values of intangible assets include discounted future cash flows, customer attrition rates, and royalty rates.


9


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

The excess of the total purchase price over the total fair value of the identifiable assets and liabilities was recorded as goodwill. The goodwill recognized is primarily attributable to the assembled workforce and synergies. None of the goodwill resulting from this acquisition is tax deductible. Goodwill has been allocated to the PD segment, which is the segment expected to benefit from the acquisition.

Pro-forma financial information has not been provided as the acquisition did not have a material impact on the Consolidated Statements of Earnings.

Other Acquisitions

On January 19, 2018, the Company acquired substantially all of the assets of Compex Corporation ("Compex") for $16.0 million, plus purchase price adjustments for a net amount of $18.7 million. The asset purchase agreement relating to the acquisition provided for a $0.6 million post-closing working capital adjustment that settled during the second quarter of 2018 as well as a $1.0 million holdback that will be paid eighteen months from the completion of the acquisition and is recorded in the Other accrued expenses line on the Consolidated Balance Sheets. The acquired business provides single layer electronic components to the telecommunication, fiber optics, defense, and aerospace markets. The transaction was accounted for under the acquisition method of accounting and the results of operations are included in the Consolidated Financial Statements from the date of acquisition in the PD segment. Included in the Consolidated Statements of Earnings are Compex's revenues and earnings before income taxes of $5.8 million and $1.0 million, respectively, from the date of acquisition through June 30, 2018.

On January 11, 2017, the Company completed an acquisition of certain assets of a capacitors manufacturer for cash consideration of $3.7 million, of which $2.5 million was paid during the first quarter of 2017. An additional $1.0 million was paid during the year ended December 31, 2018, with the remaining $0.2 million paid in the first quarter of 2019. The financial results of this acquisition were included in the Consolidated Financial Statements from the date of acquisition within the PD segment.

5. Inventories, net

The following table details the major components of inventories, net:
(in millions)
June 30, 2019
 
December 31, 2018
Raw materials
$
79.6

 
$
70.8

Work in progress
32.6

 
30.2

Finished goods
72.5

 
65.3

Subtotal
184.7

 
166.3

Less reserves
(25.0
)
 
(26.2
)
Total
$
159.7

 
$
140.1



6. Property, Plant, and Equipment, net

The following table details the major components of property, plant, and equipment, net:
(in millions)
June 30, 2019
 
December 31, 2018
Land
$
7.6

 
$
7.5

Buildings and improvements
104.0

 
102.3

Machinery, equipment, and other
519.9

 
499.9

Subtotal
631.5

 
609.7

Less accumulated depreciation
(419.6
)
 
(398.0
)
Total
$
211.9

 
$
211.7



Depreciation expense totaled $12.0 million and $11.5 million for the three months ended June 30, 2019 and 2018, respectively. For the six months ended June 30, 2019 and 2018, depreciation expense totaled $23.5 million and $23.4 million, respectively.


10


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

7. Goodwill and Other Intangible Assets

The changes in carrying value of goodwill by reportable segment for the six months ended June 30, 2019 are as follows:
(in millions)
Audio
 
Precision Devices
 
Total
Balance at December 31, 2018
$
859.9

 
$
28.0

 
$
887.9

Acquisition

 
3.2

 
3.2

Balance at June 30, 2019
$
859.9

 
$
31.2

 
$
891.1



The gross carrying value and accumulated amortization for each major class of intangible assets are as follows:
 
June 30, 2019
 
December 31, 2018
(in millions)
Gross Carrying
Amount
 
Accumulated
Amortization
 
Gross Carrying
Amount
 
Accumulated
Amortization
Amortized intangible assets:
 
 
 
 
 
 
 
Trademarks
$
1.2

 
$
0.3

 
$
0.5

 
$
0.2

Patents
40.8

 
29.2

 
40.8

 
26.9

Customer relationships
12.0

 
2.8

 
10.6

 
2.0

Unpatented technologies
3.2

 
0.5

 
4.4

 
2.7

Other
0.2

 

 
0.2

 

Total
57.4

 
32.8

 
56.5

 
31.8

Unamortized intangible assets:
 
 
 
 
 
 
 
Trademarks
32.0

 
 
 
32.0

 
 
Total intangible assets, net
$
56.6

 
 
 
$
56.7

 
 


Amortization expense totaled $1.7 million and $1.6 million for the three months ended June 30, 2019 and 2018, respectively. For the six months ended June 30, 2019 and 2018, amortization expense was $3.5 million and $3.2 million, respectively. Amortization expense for the next five years, based on current intangible balances, is estimated to be as follows:
(in millions)
 
Q3 - Q4 2019
$
3.5

2020
6.9

2021
6.9

2022
1.6

2023
1.6



8. Leases

The Company determines whether an arrangement is a lease at contract inception. Lease liabilities and right-of-use assets are recognized on the lease commencement date based on the net present value of fixed lease payments over the lease term. The Company includes options to extend or terminate a lease within the lease term when it is reasonably certain the option will be exercised. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets. Lease liabilities represent an obligation to make lease payments arising from a lease while right-of-use assets represent a right to use an underlying asset during the lease term. Right-of-use assets include prepaid fixed lease payments and exclude lease incentives. As the Company's leases generally do not have a readily determinable implicit rate, the Company uses its incremental borrowing rate to determine the present value of fixed lease payments based on information available at the lease commencement date.

Fixed lease expense for operating leases and right-of-use asset amortization for finance leases are generally recognized on a straight-line basis over the lease term. Variable lease payments, such as payments based on an index rate or usage, are expensed as incurred and excluded from lease liabilities and right-of-use assets. The Company combines lease components and nonlease components such as maintenance into a single lease component, which results in the capitalization of all fixed payments within lease liabilities and right-of-use assets.

11


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 


The Company has leases for manufacturing, sales, support, and engineering facilities, certain manufacturing and office equipment, and vehicles. The majority of the leases have remaining terms of 1 to 8 years, some of which include options to extend the leases for up to 6 years, and some of which include options to terminate the leases within 1 year. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. The Company subleases certain facilities to third parties.

The following table details the components of lease cost:
(in millions)
Three Months Ended
June 30, 2019
 
Six Months Ended
June 30, 2019
Operating lease cost (1)
$
2.5

 
$
5.1

Finance lease cost:
 
 
 
Amortization of right-of-use assets
0.7

 
1.0

Interest on lease liabilities

 

Sublease income
(0.7
)
 
(1.5
)
Total lease cost
$
2.5

 
$
4.6

(1) Includes short-term and variable lease costs, which were immaterial.

The components of lease cost other than Interest on lease liabilities are presented within the Cost of goods sold, Research and development expenses, and Selling and administrative expenses lines on the Consolidated Statements of Earnings based on the use of the underlying assets. Interest on lease liabilities is presented within the Interest expense, net line on the Consolidated Statements of Earnings.

The following table presents supplemental balance sheet information related to finance leases:
(in millions)
Balance Sheet Line
June 30, 2019
Finance lease right-of-use assets
Property, plant, and equipment, net
$
12.9

 
 
 
Current finance lease liabilities
Other accrued expenses
$
2.3

Long-term finance lease liabilities
Other liabilities
7.8

Total finance lease liabilities
 
$
10.1



The following table presents supplemental cash flow information related to leases:
(in millions)
Six Months Ended
June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows from operating leases
$
5.6

Operating cash flows from finance leases
0.3

Financing cash flows from finance leases
0.9

Right-of-use assets obtained in exchange for lease obligations:
 
Operating leases
$
2.6

Finance leases
0.2




12


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

The following table details weighted-average remaining lease terms and discount rates:
(in millions)
June 30, 2019
Weighted-average remaining lease term (in years):
 
Operating leases
4.7

Finance leases
5.6

Weighted-average discount rate:
 
Operating leases
4.3
%
Finance leases
5.6
%


The following table details maturities of lease liabilities as of June 30, 2019:
(in millions)
Operating Leases
 
Finance Leases
Q3-Q4 2019
$
5.7

 
$
1.2

2020
9.6

 
2.4

2021
9.3

 
2.3

2022
8.3

 
2.3

2023
6.3

 
2.3

2024 and thereafter
3.1

 
1.2

Total lease payments
42.3

 
11.7

Less interest
(3.8
)
 
(1.6
)
Present value of lease liabilities
$
38.5

 
$
10.1



The aggregate future minimum lease payments for capital and operating leases as of December 31, 2018 were as follows:
(in millions)
Operating Leases
 
Capital Leases
2019
$
9.7

 
$
2.3

2020
9.3

 
2.3

2021
8.8

 
2.3

2022
8.1

 
2.3

2023
6.1

 
2.3

2024 and thereafter
3.8

 
2.6

Total minimum lease payments
45.8

 
14.1

Less sublease rental income
(8.8
)
 

Net minimum lease payments
$
37.0

 
14.1

Less imputed interest
 
 
(1.6
)
Present value of capital lease obligations
 
 
$
12.5



9. Restructuring and Related Activities

Restructuring and related activities are designed to better align the Company's operations with current market conditions through targeted facility consolidations, headcount reductions, and other measures to further optimize operations.

During the three and six months ended June 30, 2019, the Company recorded restructuring charges of $0.4 million and $0.9 million, respectively, within Gross profit, primarily for actions associated with transferring certain operations of capacitors manufacturing to other existing facilities in order to further optimize operations in the PD segment. During the three and six months ended June 30, 2019, the Company also recorded restructuring charges of $0.1 million and $1.9 million, respectively, within Operating expenses, primarily for actions associated with rationalizing the Audio segment workforce.


13


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

During the three and six months ended June 30, 2018, the Company recorded restructuring charges of $0.1 million within Gross profit for actions associated with rationalizing the workforce in the Precision Devices segment. During the three and six months ended June 30, 2018, the Company recorded restructuring charges of $0.5 million and $0.9 million, respectively, within Operating expenses primarily for actions associated with rationalizing the workforce.

The following table details restructuring charges incurred by reportable segment for the periods presented:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(in millions)
2019
 
2018
 
2019
 
2018
Audio
$
0.1

 
$
0.5

 
$
1.9

 
$
0.8

Precision Devices
0.4

 
0.1

 
0.7

 
0.2

Corporate

 

 
0.2

 

Total
$
0.5

 
$
0.6

 
$
2.8

 
$
1.0



The following table details the Company’s severance and other restructuring accrual activity:
(in millions)
Severance Pay and Benefits
 
Contract Termination and Other Costs
 
Total
Balance at December 31, 2018
$
0.8

 
$
0.3

 
$
1.1

Restructuring charges
2.8

 

 
2.8

Payments
(2.3
)
 

 
(2.3
)
Other (1)

 
(0.3
)
 
(0.3
)
Balance at June 30, 2019
$
1.3

 
$

 
$
1.3


(1) Contract termination accruals related to leases of $0.3 million were reclassified to the related operating lease right-of-use assets upon adoption of ASC 842 on January 1, 2019.

The severance and restructuring accruals are recorded in the following line items on the Consolidated Balance Sheets:
(in millions)
June 30, 2019
 
December 31, 2018
Other accrued expenses
$
1.3

 
$
0.9

Other liabilities

 
0.2

Total
$
1.3

 
$
1.1



10. Hedging Transactions and Derivative Instruments

The Company is affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company’s financial performance and are referred to as "market risks." The Company uses derivatives as a risk management tool to mitigate the potential impact of certain market risks, which are primarily foreign currency risk and interest rate risk related to ongoing business operations.

Cash Flow Hedging

The Company uses cash flow hedges to minimize the variability in cash flows of assets, liabilities, or forecasted transactions caused by fluctuations in foreign currency exchange rates or market interest rates. These derivatives, which are designated cash flow hedges, are carried at fair value. The changes in their fair values are recorded to Accumulated Other Comprehensive Income (Loss) ("AOCI") and reclassified in current earnings when the hedge contract matures or becomes ineffective.

To manage its exposure to foreign currency exchange rates, the Company has entered into currency deliverable forward contracts. These derivative instruments allow the Company to hedge portions of its forecasted intercompany sales, which are expected to occur within the next twelve months and are denominated in non-functional currencies. The Company maintains a foreign currency cash flow hedging program primarily to reduce the risk that the net U.S. dollar cash inflows from non-U.S. dollar sales and non-U.S. dollar net cash outflows from procurement activities will be adversely affected by changes in foreign currency exchange rates. At June 30, 2019 and December 31, 2018, the notional value of the derivatives related to currency forward contracts, principally the Chinese yuan, Malaysian ringgit, and Philippine peso, was $44.2 million and $41.6 million, respectively.


14


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

To manage its exposure to market risk for changes in interest rates, the Company entered into an interest rate swap on November 12, 2014 to convert variable interest rate payments into fixed payments. The Company designated the swap as a cash flow hedge with re-measurement gains and losses recorded through AOCI. The interest rate swap ended in July 2018 and had a notional amount of $50.0 million during the six months ended June 30, 2018.

Economic (Non-Designated) Hedging

In addition to derivative instruments that are designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign currency risk. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effectively economic hedges. The changes in fair value of these economic hedges are immediately recognized in earnings.

The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and liabilities denominated in non-functional currencies. The Company does not enter into these hedges for speculative reasons. These derivatives are carried at fair value with changes in fair value immediately recognized in earnings within Other (income) expense, net. In addition, these derivative instruments minimize the impact of exchange rate movements on the Company’s balance sheet, as the gains or losses on these derivatives are intended to offset gains and losses from the reduction of the hedged assets and liabilities. At June 30, 2019 and December 31, 2018, the notional value of the derivatives related to economic hedging was $31.4 million and $19.8 million, respectively.

The notional amounts of the derivative financial instruments do not necessarily represent amounts exchanged by the parties and, therefore, are not a direct measure of our exposure to the financial risks described above. The amounts exchanged are calculated by reference to the notional amounts and by other terms of the derivatives, such as interest rates, foreign currency exchange rates, or other financial indices. The Company does not view the fair values of its derivatives in isolation, but rather in relation to the fair values or cash flows of the underlying hedged transactions or other exposures. Virtually all of our derivatives are straightforward over-the-counter instruments with liquid markets.

Fair Value Measurements

All derivatives are carried at fair value on the Company’s Consolidated Balance Sheets. ASC 820, Fair Value Measurement, establishes a fair value hierarchy that requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the hierarchy is based on the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value as follows:

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices in active markets for similar assets and liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of assets or liabilities.

Level 3 - Unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.

The Company determines the fair values of its derivatives based on standard valuation models or observable market inputs such as quoted market prices, foreign currency exchange rates, or interest rates; therefore, the Company classifies the derivatives within Level 2 of the valuation hierarchy.


15


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

The fair values of derivative instruments held by the Company are as follows (in millions):
 
 
 
Derivative Assets (Liabilities)
Hedge Type
Contract Type
Balance Sheet Line
June 30, 2019
 
December 31, 2018
Derivatives designated as hedging instruments
 
 
 
Cash flow hedges
Foreign exchange contracts
Prepaid and other current assets
$
0.3

 
$
0.2

Cash flow hedges
Foreign exchange contracts
Other accrued expenses
(0.4
)
 
(0.6
)
 
 
 
 
 
 
Derivatives not designated as hedging instruments
 
 
 
Economic hedges
Foreign exchange contracts
Prepaid and other current assets

 
0.2

Economic hedges
Foreign exchange contracts
Other accrued expenses
(0.1
)
 



The pre-tax amount of unrealized (loss) gain recognized in accumulated other comprehensive loss on derivatives designated as hedging instruments is as follows (in millions):
 
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
Hedge Type
Contract Type
 
2019
 
2018
 
2019
 
2018
Cash flow hedges
Foreign exchange contracts
 
$
(0.5
)
 
$
(2.5
)
 
$
0.2

 
$
(1.5
)
Cash flow hedges
Interest rate contracts
 

 

 

 
0.1


The table above excludes tax benefit of $0.1 million and $0.5 million for the three months ended June 30, 2019 and 2018, respectively. There was no tax expense and a tax benefit of $0.2 million for the six months ended June 30, 2019 and 2018, respectively.

The pre-tax impact of derivatives on the Consolidated Statements of Earnings is as follows (in millions):
 
 
 
Three Months Ended June 30,
 
 
 
2019
 
2018
Hedge Type
Contract Type
 
Cost of goods sold
Interest expense, net
Other (income) expense, net
 
Cost of goods sold
Interest expense, net
Other (income) expense, net
Total amounts per Consolidated Statements of Earnings
 
$
128.4

$
3.6

$
(0.5
)
 
$
115.1

$
4.1

$
0.3

 
 
 
 
 
 
 
 
 
 
Effect of derivatives designated as hedging instruments
Amount of gain reclassified from accumulated other comprehensive loss into earnings:
 
 
 
Cash flow hedges
Foreign exchange contracts
 



 



Cash flow hedges
Interest rate contracts
 



 

(0.1
)

 
 
 
 
 
 
 
 
 
 
Effect of derivatives not designated as hedging instruments
Amount of loss recognized in earnings:
 
 
 
 
 
 
 
 
Economic hedges
Foreign exchange contracts
 


0.2

 


0.8




16


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

 
 
 
Six Months Ended June 30,
 
 
 
2019
 
2018
Hedge Type
Contract Type
 
Cost of goods sold
Interest expense, net
Other (income) expense, net
 
Cost of goods sold
Interest expense, net
Other (income) expense, net
Total amounts per Consolidated Statements of Earnings
 
$
239.2

$
7.1

$
0.5

 
$
228.3

$
8.1

$
0.2

 
 
 
 
 
 
 
 
 
 
Effect of derivatives designated as hedging instruments
Amount of loss (gain) reclassified from accumulated other comprehensive loss into earnings:
 
 
 
Cash flow hedges
Foreign exchange contracts
 
0.2



 
(0.8
)


Cash flow hedges
Interest rate contracts
 



 



 
 
 
 
 
 
 
 
 
 
Effect of derivatives not designated as hedging instruments
Amount of loss recognized in earnings:
 
 
 
 
 
 
 
 
Economic hedges
Foreign exchange contracts
 


0.2

 


0.4



11. Borrowings

Borrowings (net of debt issuance costs, debt discount, and amortization) consist of the following:
(in millions)
June 30, 2019
 
December 31, 2018
3.25% convertible senior notes
$
152.9

 
$
149.1

Revolving credit facility
19.0

 
9.0

Total
171.9

 
158.1

Less current maturities (1)

 

Total long-term debt
$
171.9

 
$
158.1


(1) There are no required principal payments due under the 3.25% convertible senior notes or the revolving credit facility until maturities in November 2021 and October 2022, respectively.

Total debt principal payments over the next five years are as follows:
(in millions)
Q3-Q4 2019
 
2020
 
2021
 
2022
 
2023
Debt principal payments
$

 
$

 
$
172.5

 
$
19.0

 
$



3.25% Convertible Senior Notes Due November 1, 2021

In May 2016, the Company issued $172.5 million aggregate principal amount of 3.25% convertible senior notes due November 1, 2021 ("the Notes"), unless earlier repurchased by the Company or converted pursuant to their terms. Interest is payable semiannually in arrears on May 1 and November 1 each year and commenced on November 1, 2016.

The Notes are governed by an Indenture (the "Indenture") between the Company, as issuer, and U.S. Bank National Association as trustee. Upon conversion, the Company will pay or deliver cash, shares of the Company's common stock, or a combination of cash and shares of common stock, at the Company's election. The initial conversion rate is 54.2741 shares of common stock per $1,000 principal amount of Notes. The initial conversion price is $18.4250 per share of common stock. The conversion rate will be subject to adjustment upon the occurrence of certain specified events but will not be adjusted for accrued and unpaid interest. In addition, upon the occurrence of a make-whole fundamental change (as defined in the Indenture), the Company may be required, in certain circumstances, to increase the conversion rate by a number of additional shares for a holder that elects to convert its Notes in connection with such make-whole fundamental change.


17


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

Prior to the close of business on the business day immediately preceding August 1, 2021, the Notes will be convertible only under the following circumstances:
=
during any calendar quarter and only during such calendar quarters, if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
=
during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Notes was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; or
=
upon the occurrence of specified corporate events.

On or after August 1, 2021 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances. As of June 30, 2019, no event has occurred that would permit the conversion of the Notes. The Notes are the Company’s senior unsecured obligations.

In accounting for the issuance of the Notes, the Company separated the Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the face value of the Notes as a whole. The excess of the principal amount of the liability component over its carrying amount is amortized to interest expense over the term of the Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification.

In accounting for the transaction costs related to the Notes issuance, the Company allocated the total amount incurred to the liability and equity components based on their relative values. Issuance costs attributable to the liability component, totaling $5.0 million, are being amortized to interest expense over the term of the Notes, and issuance costs attributable to the equity component, totaling $1.3 million, were netted with the equity component in stockholders' equity.

The Notes consist of the following:
(in millions)
June 30, 2019
 
December 31, 2018
Liability component:
 
 
 
Principal
$
172.5

 
$
172.5

Less debt issuance costs and debt discount, net of amortization
(19.6
)
 
(23.4
)
Total
152.9

 
149.1

Less current maturities (1)

 

Long-term portion
$
152.9

 
$
149.1

 
 
 
 
Equity component (2)
$
29.9

 
$
29.9

(1) There are no required principal payments due until maturity in November 2021.
(2) Recorded in the Consolidated Balance Sheets within additional paid-in capital, inclusive of the $1.3 million of issuance costs in equity.

The total estimated fair value of the Notes at June 30, 2019 was $205.8 million. The fair value was determined based on the closing trading price of the Notes as of the last trading day for the second quarter of 2019.


18


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

The following table sets forth total interest expense recognized related to the Notes:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(in millions)
2019
 
2018
 
2019
 
2018
3.25% coupon
$
1.4

 
$
1.4

 
$
2.8

 
$
2.8

Amortization of debt issuance costs
0.2

 
0.2

 
0.4

 
0.4

Amortization of debt discount
1.7

 
1.6

 
3.4

 
3.1

Total
$
3.3

 
$
3.2

 
$
6.6

 
$
6.3



Note Hedges

To minimize the impact of potential economic dilution upon conversion of the Notes, the Company entered into convertible note hedge transactions (the “Note Hedges”) with respect to its common stock. In the second quarter of 2016, the Company paid an aggregate amount of $44.5 million for the Note Hedges. The Note Hedges will expire upon maturity of the Notes. The Note Hedges are intended to offset the potential dilution upon conversion of the Notes and/or offset any cash payments the Company is required to make in excess of the principal amount upon conversion of the Notes in the event that the market value per share of the Company's common stock, as measured under the Note Hedges, is greater than the strike price of the Note Hedges, which initially corresponds to the initial conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes. The Note Hedges are separate transactions entered into by the Company, and are not part of the Notes or the Warrants, and have been accounted for as part of additional paid-in capital. Holders of the Notes do not have any rights with respect to the Note Hedges.

Warrants

In addition to the Note Hedges, in the second quarter of 2016, the Company entered into warrant transactions, whereby the Company sold warrants to acquire shares of the Company's common stock at a strike price of $21.1050 per share (the “Warrants”). The Company received aggregate proceeds of $39.1 million from the sale of the Warrants. If the market price per share of the Company's common stock for the reporting period, as measured under the Warrants, exceeds the strike price of the Warrants, the Warrants could have a dilutive effect on the Company's common stock, unless the Company elects, subject to certain conditions, to settle the Warrants in cash. The Warrants are separate transactions entered into by the Company, and are not part of the Notes or the Note Hedges, and have been accounted for as part of additional paid-in capital. Holders of the Notes and Note Hedges do not have any rights with respect to the Warrants.

Revolving Credit Facility

Revolving credit facility borrowings consist of the following:
(in millions)
June 30, 2019
 
December 31, 2018
$400.0 million revolving credit facility due October 2022
$
19.0

 
$
9.0

Less current maturities (1)

 

Long-term portion
$
19.0

 
$
9.0


(1) There are no required principal payments due until maturity in October 2022.

On October 11, 2017, the Company entered into a Revolving Credit Facility Agreement (the "New Credit Facility"). The New Credit Facility contains a five-year senior secured revolving credit facility providing for borrowings in an aggregate principal amount at any time outstanding not to exceed $400.0 million. The New Credit Facility serves as refinancing of indebtedness and terminates the Company's Amended and Restated Credit Agreement dated as of January 27, 2014, as amended and restated as of December 31, 2014 and supplemented from time to time (“Prior Credit Facilities”).


19


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

The New Credit Facility includes requirements, to be tested quarterly, that the Company maintains (i) a minimum ratio of Consolidated EBITDA to consolidated interest expense of 3.25 to 1.0 (the "Interest Coverage Ratio"), (ii) a maximum ratio of Consolidated total indebtedness to Consolidated EBITDA of 3.75 to 1.0 (the "Leverage Ratio"), and (iii) a maximum ratio of senior secured indebtedness to Consolidated EBITDA of 3.25 to 1.0 (the "Senior Secured Leverage Ratio"). For these ratios, Consolidated EBITDA and consolidated interest expense are calculated using the most recent four consecutive fiscal quarters in a manner defined in the New Credit Facility. At June 30, 2019, the Company was in compliance with these covenants and it expects to remain in compliance with all of its debt covenants over the next twelve months.

The interest rate under the New Credit Facility is variable based on LIBOR at the time of the borrowing and the Company’s leverage as measured by a total indebtedness to Consolidated EBITDA ratio. Based upon the Company’s total indebtedness to Consolidated EBITDA ratio, the Company’s borrowing rate could range from LIBOR + 1.25% to LIBOR + 2.25%. In addition, a commitment fee accrues on the average daily unused portion of the New Credit Facility at a rate of 0.20% to 0.35%.

The weighted-average interest rate on the Company's borrowings under the New Credit Facility was 3.99% and 3.49% for the six months ended June 30, 2019 and 2018, respectively. The weighted-average interest rate on the Company's borrowings under the New Credit Facility for the six months ended June 30, 2018 includes interest expense related to the monthly interest rate swap settlements that ended in July 2018. The weighted-average commitment fee on the revolving line of credit was 0.23% and 0.25% for the six months ended June 30, 2019 and 2018, respectively.

See Note 10. Hedging Transactions and Derivative Instruments for information on derivatives used to manage interest rate risk.


20


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

12. Other Comprehensive Earnings

The amounts recognized in other comprehensive (loss) earnings were as follows:
 
Three Months Ended
 
Three Months Ended
 
June 30, 2019
 
June 30, 2018
(in millions)
Pre-tax
 
Tax
 
Net of tax
 
Pre-tax
 
Tax
 
Net of tax
Foreign currency translation
$
(2.5
)
 
$

 
$
(2.5
)
 
$
(7.6
)
 
$

 
$
(7.6
)
Employee benefit plans
0.2

 

 
0.2

 
0.2

 

 
0.2

Changes in fair value of cash flow hedges
(0.5
)
 
0.1

 
(0.4
)
 
(2.6
)
 
0.5

 
(2.1
)
Total other comprehensive loss
$
(2.8
)
 
$
0.1

 
$
(2.7
)
 
$
(10.0
)
 
$
0.5

 
$
(9.5
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended
 
Six Months Ended
 
June 30, 2019
 
June 30, 2018
(in millions)
Pre-tax
 
Tax
 
Net of tax
 
Pre-tax
 
Tax
 
Net of tax
Foreign currency translation
$
1.5

 
$

 
$
1.5

 
$
(2.7
)
 
$

 
$
(2.7
)
Employee benefit plans
0.3

 

 
0.3

 
0.3

 

 
0.3

Changes in fair value of cash flow hedges
0.4

 
(0.1
)
 
0.3

 
(2.2
)
 
0.3

 
(1.9
)
Total other comprehensive earnings (loss)
$
2.2

 
$
(0.1
)
 
$
2.1

 
$
(4.6
)
 
$
0.3

 
$
(4.3
)

The following tables summarize the changes in balances of each component of accumulated other comprehensive loss, net of tax during the six months ended June 30, 2019 and 2018:
(in millions)
Cash flow hedges
 
Employee benefit plans
 
Cumulative foreign currency translation adjustments
 
Total
Balance at December 31, 2018
$
(0.4
)
 
$
(15.5
)
 
$
(95.1
)
 
$
(111.0
)
Other comprehensive earnings, net of tax
0.3


0.3

 
1.5

 
2.1

Balance at June 30, 2019
$
(0.1
)
 
$
(15.2
)
 
$
(93.6
)
 
$
(108.9
)


(in millions)
Cash flow hedges
 
Employee benefit plans
 
Cumulative foreign currency translation adjustments
 
Total
Balance at December 31, 2017
$
0.5

 
$
(15.3
)
 
$
(85.2
)
 
$
(100.0
)
Other comprehensive (loss) earnings, net of tax
(1.9
)
 
0.3

 
(2.7
)
 
(4.3
)
Balance at June 30, 2018
$
(1.4
)
 
$
(15.0
)
 
$
(87.9
)
 
$
(104.3
)



21


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

The following tables summarize the amounts reclassified from accumulated other comprehensive loss to earnings:
 
 
Three Months Ended June 30,
(in millions)
Statement of Earnings Line
2019
 
2018
Pension and post-retirement benefit plans:
 
 
 
 
Amortization or settlement of actuarial losses and prior service costs

Other (income) expense, net
$
0.2

 
$
0.2

Tax
Provision for income taxes

 

Net of tax
 
$
0.2

 
$
0.2

 
 
 
 
 
Cash flow hedges:
 
 
 
 
Net gains reclassified into earnings
Various (1)
$

 
$
(0.1
)
Tax
Provision for income taxes

 

Net of tax
 
$

 
$
(0.1
)
 
 
 
 
 
 
 
Six Months Ended June 30,
(in millions)
Statement of Earnings Line
2019
 
2018
Pension and post-retirement benefit plans:
 
 
 
 
Amortization or settlement of actuarial losses and prior service costs

Other (income) expense, net
$
0.3

 
$
0.3

Tax
Provision for income taxes

 

Net of tax
 
$
0.3

 
$
0.3

 
 
 
 
 
Cash flow hedges:
 
 
 
 
Net losses (gains) reclassified into earnings
Various (1)
$
0.2

 
$
(0.8
)
Tax
Provision for income taxes
(0.1
)
 
0.1

Net of tax
 
$
0.1

 
$
(0.7
)
(1) See Note 10. Hedging Transactions and Derivative Instruments for additional information.

13. Income Taxes

Income taxes for the interim periods presented have been included in the accompanying Consolidated Financial Statements on the basis of an estimated annual effective tax rate ("ETR"). The determination of the consolidated provision for income taxes requires management to make certain judgments and estimates. Changes in the estimated level of annual pre-tax earnings or loss, tax laws, and changes resulting from tax audits can affect the overall ETR, which impacts the level of income tax expense or benefit and net income or loss. Judgments and estimates related to the Company’s projections and assumptions are inherently uncertain and therefore, actual results could differ materially from projections.

The Company's ETR from continuing operations for the three and six months ended June 30, 2019 was a 36.6% provision and a 65.2% provision, respectively. The Company's ETR from continuing operations for the three and six months ended June 30, 2018 was a 24.1% provision and a 35.5% provision, respectively. The changes in ETR were due to the mix of earnings and losses by taxing jurisdictions. The ETR is favorably impacted by two tax holidays granted to the Company in Malaysia effective through December 31, 2021. These tax holidays are subject to the Company's annual satisfaction of certain conditions, including investment and sales thresholds. If the Company fails to satisfy such conditions, the Company's ETR may be significantly adversely impacted. The continuing operations benefit of our tax holidays in Malaysia for the three and six months ended June 30, 2019 was approximately $4.5 million and $7.9 million, respectively, or $0.05 and $0.09 on a per share basis. The continuing operations benefit of these incentives for the three and six months ended June 30, 2018 was approximately $2.6 million and $4.1 million, respectively, or $0.03 and $0.05 on a per share basis.


22


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

14. Equity Incentive Program

Stock-based compensation expense recognized in the Consolidated Statements of Earnings totaled $7.3 million for the three months ended June 30, 2019 and 2018. For the six months ended June 30, 2019 and 2018, stock-based compensation expense was $14.0 million and $14.3 million, respectively.

Stock Options and SSARs

The expense related to stock options granted in the six months ended June 30, 2019 and 2018 was estimated on the date of grant using a Black-Scholes option-pricing model based on the assumptions shown in the table below:
 
Six Months Ended June 30,
 
2019
 
2018
Risk-free interest rate
2.29%
to
2.44%
 
2.59%
Dividend yield
—%
 
—%
Expected life (years)
4.5
 
4.5
Volatility
41.8%
to
42.9%
 
41.2%
Fair value at date of grant
$6.22
to
$6.55
 
$4.83
to
$5.39


The following table summarizes the Company's stock-settled stock appreciation right ("SSAR") and stock option activity for the six months ended June 30, 2019 (in millions, except share and per share amounts):
 
SSARs
 
Stock Options
 
Number of Shares
 
Weighted-Average Exercise Price
 
Aggregate Intrinsic Value
 
Weighted-Average Remaining Contractual Term (Years)
 
Number of Shares
 
Weighted-Average Exercise Price
 
Aggregate Intrinsic Value
 
Weighted-Average Remaining Contractual Term (Years)
Outstanding at December 31, 2018
781,995

 
$
21.85

 
 
 
 
 
5,471,493

 
$
17.64

 
 
 
 
Granted

 

 
 
 
 
 
857,504

 
16.11

 
 
 
 
Exercised
(22,420
)
 
14.28

 
 
 
 
 
(117,750
)
 
14.22

 
 
 
 
Forfeited

 

 
 
 
 
 
(65,504
)
 
15.86

 
 
 
 
Expired
(100,980
)
 
22.58

 
 
 
 
 
(26,805
)
 
26.30

 
 
 
 
Outstanding at June 30, 2019
658,595

 
$
21.99

 
$
0.2

 
2.7
 
6,118,938

 
$
17.47

 
$
16.7

 
4.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at June 30, 2019
658,595

 
$
21.99

 
$
0.2

 
2.7
 
4,441,673

 
$
18.07

 
$
12.4

 
3.3


There was no unrecognized compensation expense related to SSARs at June 30, 2019. At June 30, 2019, unrecognized compensation expense related to stock options not yet exercisable of $8.3 million is expected to be recognized over a weighted-average period of 1.5 years.

23


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 


RSUs

The following table summarizes the Company's restricted stock unit ("RSU") activity for the six months ended June 30, 2019:
 
Share units
 
Weighted-average grant date fair value
Unvested at December 31, 2018
2,446,431

 
$
15.12

Granted
1,450,362

 
16.08

Vested
(1,082,903
)
 
14.67

Forfeited
(177,913
)
 
15.50

Unvested at June 30, 2019
2,635,977

 
$
15.80



At June 30, 2019, $34.1 million of unrecognized compensation expense related to RSUs is expected to be recognized over a weighted-average period of 1.5 years.

PSUs

The Company grants performance stock units ("PSUs") to senior management. In each case, the awards will cliff vest three years following the grant date. For the awards granted in February 2018 and 2017, the number of PSUs that may be earned and vest is based on the Company's revenues and stock price performance over a three year performance period. For the awards granted in February 2019, the number of PSUs that may be earned and vest is based on the Company's revenues and total shareholder return relative to the S&P Semiconductor Select Industry Index over a three year performance period. PSUs will be settled in shares of the Company's common stock. Depending on the Company's overall performance relative to the applicable performance metrics, the size of the PSU awards are subject to adjustment, up or down, resulting in awards at the end of the performance period that can range from 0% to 225% of the initial grant value. The Company will ratably recognize the expense over the applicable service period for each grant of PSUs and adjust the expense as appropriate. The fair value of the PSUs is determined by using a Monte Carlo simulation.

The following table summarizes the Company's PSU activity for the six months ended June 30, 2019:
 
Share units
 
Weighted-average grant date fair value
Unvested at December 31, 2018
557,967

 
$
14.27

Granted
294,678

 
18.41

Vested

 

Forfeited
(39,934
)
 
15.65

Unvested at June 30, 2019
812,711

 
$
15.70



At June 30, 2019, $10.1 million of unrecognized compensation expense related to PSUs is expected to be recognized over a weighted-average period of 2.2 years.


24


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

15. Earnings per Share

Basic and diluted earnings per share were computed as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(in millions, except share and per share amounts)
2019
 
2018
 
2019
 
2018
Earnings from continuing operations
$
5.9

 
$
4.4

 
$
3.2

 
$
4.0

Earnings from discontinued operations, net

 
0.2

 

 
0.3

Net earnings
$
5.9

 
$
4.6

 
$
3.2

 
$
4.3

 
 
 
 
 
 
 
 
Basic earnings per common share:
 
 
 
 
 
 
 
Earnings from continuing operations
$
0.06

 
$
0.05

 
$
0.04

 
$
0.04

Earnings from discontinued operations, net

 

 

 
0.01

Net earnings
$
0.06

 
$
0.05

 
$
0.04

 
$
0.05

 
 
 
 
 
 
 
 
Weighted-average shares outstanding
91,018,213

 
90,063,089

 
90,780,035

 
89,893,557

 
 
 
 
 
 
 
 
Diluted earnings per common share:
 

 
 

 
 
 
 
Earnings from continuing operations
$
0.06

 
$
0.05

 
$
0.03

 
$
0.04

Earnings from discontinued operations, net

 

 

 
0.01

Net earnings
$
0.06

 
$
0.05

 
$
0.03

 
$
0.05

 
 
 
 
 
 
 
 
Diluted weighted-average shares outstanding
92,507,279

 
90,731,760

 
92,184,274

 
90,718,298



For the three and six months ended June 30, 2019, the weighted-average number of anti-dilutive potential common shares excluded from the diluted earnings per share calculation above was 4,306,633 and 4,457,926, respectively. For the three and six months ended June 30, 2018, the weighted-average number of anti-dilutive potential common shares excluded from the diluted earnings per share calculation above was 6,277,283 and 5,892,564, respectively.

16. Commitments and Contingent Liabilities

From time to time, the Company is involved in various legal proceedings and claims arising in the ordinary course of its business. The majority of these claims and proceedings relate to commercial, warranty, employment, and intellectual property matters. Although the ultimate outcome of any legal proceeding or claim cannot be predicted with certainty, based on present information, including management’s assessment of the merits of the particular claim, the Company does not believe that the disposition of these legal proceedings or claims, individually or in the aggregate, after taking into account recorded accruals and the availability and limits of insurance coverage, will have a material adverse effect on its cash flow, results of operations, or financial condition.

Intellectual Property Infringement Claims

The Company owns many patents and other intellectual property pertaining to its products, technology, and manufacturing processes. Some of its patents have been and may continue to be infringed or challenged by others. In appropriate cases, the Company has taken and will take steps to protect and defend its patents and other intellectual property, including through the use of legal proceedings in various jurisdictions around the world. Such steps have resulted in and may continue to result in retaliatory legal proceedings, including litigation or other legal proceedings in various jurisdictions and forums around the world alleging infringement by the Company of patents owned by others. The costs of investigations and legal proceedings, particularly multi-forum litigation, relating to the enforcement and defense of the Company’s intellectual property, may be substantial. Additionally, in multi-forum disputes, the Company may incur adverse judgments with regard to certain claims in certain jurisdictions and forums while still contesting other related claims against the same opposing party in other jurisdictions and forums.


25


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

The Company may, on a limited customer specific basis, provide contractual indemnities for certain losses that arise out of claims that its products infringe on the intellectual property of others. Historically, the Company has not made significant payments under such indemnity arrangements. The Company’s legal accruals were not significant at June 30, 2019 and December 31, 2018.

17. Segment Information

The Company's two reportable segments are Audio and Precision Devices. Information regarding the Company's reportable segments is as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(in millions)
2019
 
2018
 
2019
 
2018
Revenues:
 
 
 
 
 
 
 
Audio
$
159.9

 
$
151.8

 
$
299.0

 
$
298.2

Precision Devices
45.3

 
36.6

 
86.0

 
68.7

Total revenues
$
205.2

 
$
188.4

 
$
385.0

 
$
366.9

 
 
 
 
 
 
 
 
Earnings from continuing operations before interest and income taxes:
Audio
$
21.2

 
$
17.3

 
$
33.0

 
$
29.6

Precision Devices
8.2

 
6.4

 
15.7

 
12.6

Total segments
29.4

 
23.7

 
48.7

 
42.2

Corporate expense / other
16.5

 
13.8

 
32.4

 
27.9

Interest expense, net
3.6

 
4.1

 
7.1

 
8.1

Earnings before income taxes and discontinued operations
9.3

 
5.8

 
9.2

 
6.2

Provision for income taxes
3.4

 
1.4

 
6.0

 
2.2

Earnings from continuing operations
$
5.9

 
$
4.4

 
$
3.2

 
$
4.0



Information regarding assets of the Company's reportable segments:
 
Total Assets
(in millions)
June 30, 2019
 
December 31, 2018
Audio
$
1,418.2

 
$
1,409.1

Precision Devices
162.6

 
136.9

Corporate / eliminations
5.0

 
1.9

Total
$
1,585.8

 
$
1,547.9



The following table details revenues by geographic location. Revenues are attributed to regions based on the location of the Company's direct customer, which in some instances is an intermediary and not necessarily the end user. The Company's businesses are based primarily in Asia, North America, and Europe.
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(in millions)
2019
 
2018
 
2019
 
2018
Asia
$
144.0

 
$
131.8

 
$
265.1

 
$
257.8

United States
32.9

 
32.4

 
65.1

 
62.0

Europe
25.1

 
21.7

 
48.9

 
42.2

Other Americas
1.6

 
0.9

 
2.7

 
1.8

Other
1.6

 
1.6

 
3.2

 
3.1

Total
$
205.2

 
$
188.4

 
$
385.0

 
$
366.9




26


NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
(unaudited)
 

Receivables, net from contracts with customers were $126.1 million and $128.6 million as of June 30, 2019 and December 31, 2018, respectively. As of June 30, 2019, our total remaining performance obligations are immaterial.


27



Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to our operations, results of operations, and other matters that are based on our current expectations, estimates, assumptions, and projections. Words such as “believe,” “expect,” “anticipate,” “project,” “estimate,” “budget,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “seek,” “should,” “will,” “would,” “objective,” “forecast,” “goal,” “guidance,” “outlook,” “target,” and similar expressions are used to identify these forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Actual outcomes and results may differ materially from what is expressed or forecast in these forward-looking statements. Risks, uncertainties, and other factors that might cause such differences, some of which could be material, include, but are not limited to:
o
Unforeseen changes in MEMS microphone demand from our largest customers, in particular, two North American, a Korean, and Chinese original equipment manufacturer ("OEM") customers;
o
the success and rate of multi-microphone and smart microphone adoption and proliferation of our “intelligent audio” solutions, including our audio edge processors, to high volume platforms;
o
our ongoing ability to execute our strategy to diversify our end markets and customers;
o
our ability to stem or overcome price erosion in our segments;
o
fluctuations in our stock's market price;
o
fluctuations in operating results and cash flows;
o
our ability to prevent or identify quality issues in our products or to promptly remedy any such issues that are identified;
o
the timing of OEM product launches;
o
risks associated with increasing our inventories in advance of anticipated orders by customers;
o
global economic instability including the recent economic slowdown in China;
o
the impact of changes to laws and regulations that affect the Company’s ability to offer products or services to customers in different regions;
o
risks associated with shareholder activism, including proxy contests;
o
our ability to achieve continued reductions in our operating expenses;
o
our ability to obtain, enforce, defend, or monetize our intellectual property rights;
o
increases in the costs of critical raw materials and components;
o
availability of raw materials and components;
o
managing new product ramps and introductions for our customers;
o
our dependence on a limited number of large customers;
o
our ability to maintain and expand our existing relationships with leading OEMs in order to maintain and increase our revenue;
o
increasing competition and new entrants in the market for our products;
o
our ability to develop new or enhanced products or technologies in a timely manner that achieve market acceptance;
o
our reliance on third parties to manufacture, assemble, and test our products and sub-components;
o
escalating international trade tensions, new or increased tariffs, and trade wars among countries;
o
financial risks, including risks relating to currency fluctuations, credit risks, and fluctuations in the market value of the Company; and
o
changes in tax laws, changes in tax rates, and exposure to additional tax liabilities.

A more complete description of these risks, uncertainties, and other factors can be found under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018. We do not undertake to update or revise our forward-looking statements as a result of new information, future events, or otherwise, except as required by law.

28



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our Consolidated Financial Statements and related Notes included elsewhere in this Quarterly Report on Form 10-Q.

Overview

We are a market leader and global provider of advanced micro-acoustic, audio processing, and precision device solutions, serving the mobile consumer electronics, communications, medical, defense, automotive, and industrial markets. We use our leading position in micro-electro-mechanical systems ("MEMS") microphones and strong capabilities in audio processing technologies to optimize audio systems and improve the user experience in mobile, ear, and Internet of Things ("IoT") applications. We are also a leader in acoustic components, high-end capacitors, and mmWave radio frequency ("RF") solutions for a diverse set of markets. Our focus on the customer, combined with unique technology, proprietary manufacturing techniques, rigorous testing, and global scale, enables us to deliver innovative solutions that optimize the user experience. References to "Knowles," the "Company," "we," "our," or "us" refer to Knowles Corporation and its consolidated subsidiaries, unless the context otherwise requires.

We are organized into two reportable segments based on how management analyzes performance, allocates capital, and makes strategic and operational decisions. These segments were determined in accordance with Financial Accounting Standards Board Accounting Standards Codification 280 - Segment Reporting and are comprised of (i) Audio and (ii) Precision Devices ("PD"). The segments are aligned around similar product applications serving our key end markets, to enhance focus on end market growth strategies.

Audio Segment
Our Audio group designs and manufactures innovative audio products, including microphones and balanced armature speakers, audio processors, and software and algorithms used in applications that serve the mobile, ear, and IoT markets. Locations include the sales, support, and engineering facilities in North America, Europe, and Asia, as well as manufacturing facilities in Asia.

PD Segment
Our PD group specializes in the design and delivery of high performance capacitor products and mmWave RF solutions for technically demanding applications. Our high performance capacitor products are used in applications such as power supplies and medical implants, which sell to a diverse set of customers for mission critical applications across the communications, medical, defense, automotive, and industrial markets. Our mmWave RF solutions primarily solve high frequency filtering challenges for our military customers, who use them in their satellite communication and radar systems, as well as our telecommunications infrastructure customers deploying mmWave 5G base stations. Locations include the sales, support, engineering, and manufacturing facilities in North America, Europe, and Asia.

We sell our products directly to original equipment manufacturers ("OEMs") and to their contract manufacturers and suppliers and to a lesser extent through distributors worldwide.

On January 3, 2019, the Company acquired substantially all of the assets of DITF Interconnect Technology, Inc. ("DITF") for $11.1 million. The acquired business provides thin film components to the defense, telecommunication, industrial, and medical markets. This acquisition's operations are included in the PD segment. For additional information, refer to Note 4. Acquisitions to our Consolidated Financial Statements.


29

Table of Contents


Results of Operations for the Three Months Ended June 30, 2019 compared with the Three Months Ended June 30, 2018

In addition to the GAAP financial measures included herein, we have presented certain non-GAAP financial measures. We use non-GAAP measures as supplements to our GAAP results of operations in evaluating certain aspects of our business, and our executive management team and Board of Directors focus on non-GAAP items as key measures of our performance for business planning purposes. These measures assist us in comparing our performance between various reporting periods on a consistent basis, as these measures remove from operating results the impact of items that, in our opinion, do not reflect our core operating performance. We believe that our presentation of non-GAAP financial measures is useful because it provides investors and securities analysts with the same information that we use internally for purposes of assessing our core operating performance. The Company does not consider these non-GAAP financial measures to be a substitute for the information provided by GAAP financial results. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures, see the reconciliation included herein.
 
 
Three Months Ended June 30,
(in millions, except per share amounts)
 
2019
 
2018
Revenues
 
$
205.2

 
$
188.4

 
 
 
 
 
Gross profit
 
$
76.4

 
$
73.2

Non-GAAP gross profit
 
$
78.1

 
$
74.2

 
 
 
 
 
Earnings from continuing operations before interest and income taxes
 
$
12.9

 
$
9.9

Adjusted earnings from continuing operations before interest and income taxes
 
$
26.1

 
$
21.4

 
 
 
 
 
Provision for income taxes
 
$
3.4

 
$
1.4

Non-GAAP provision for income taxes
 
$
3.5

 
$
2.1

 
 
 
 
 
Earnings from continuing operations
 
$
5.9

 
$
4.4

Non-GAAP net earnings from continuing operations
 
$
20.7

 
$
16.8

 
 
 
 
 
Earnings per share from continuing operations - diluted
 
$
0.06

 
$
0.05

Non-GAAP diluted earnings per share from continuing operations
 
$
0.22

 
$
0.18


Revenues

Revenues for the second quarter of 2019 were $205.2 million, compared with $188.4 million for the second quarter of 2018, an increase of $16.8 million or 8.9%. PD revenues increased $8.7 million primarily due to higher shipments to the medical and telecommunications markets, increased revenues related to our acquisition of DITF in January 2019, and the benefit of higher pricing. Audio revenues increased $8.1 million primarily due to higher demand of MEMS microphones for Ear and IoT applications. In addition, shipments of MEMS microphones used in handset applications increased to our largest customer and a key Korean OEM, partially offset by lower demand from key Taiwanese and Chinese OEMs. Audio revenues were also impacted by lower average pricing on mature products.

Cost of Goods Sold

Cost of goods sold ("COGS") for the second quarter of 2019 was $128.4 million, compared with $115.1 million for the second quarter of 2018, an increase of $13.3 million or 11.6%. This increase was primarily the result of higher shipping volume, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, and warranty claims, partially offset by product cost improvements and favorable foreign currency exchange rate changes.


30

Table of Contents


Restructuring Charges

During the second quarter of 2019, we recorded restructuring charges of $0.4 million within Gross Profit, primarily for actions associated with transferring certain operations of capacitors manufacturing to other existing facilities in order to further optimize operations in the PD segment. The Company also recorded restructuring charges of $0.1 million within Operating expenses, primarily for actions associated with rationalizing the Audio segment workforce.

During the second quarter of 2018, we recorded total restructuring charges of $0.1 within Gross Profit, primarily for actions associated with optimizing operations in the PD segment. The Company also recorded restructuring charges of $0.5 million within Operating expenses, primarily for actions associated with reorganizing the Audio segment research and development workforce.

Gross Profit and Non-GAAP Gross Profit

Gross profit for the second quarter of 2019 was $76.4 million, compared with $73.2 million for the second quarter of 2018, an increase of $3.2 million or 4.4%. Gross profit margin (gross profit as a percentage of revenues) for the second quarter of 2019 was 37.2%, compared with 38.9% for the second quarter of 2018. The gross profit increase was primarily due to higher shipping volumes, product cost improvements, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, warranty claims, and unfavorable product mix. The gross profit margin decrease was driven by lower average pricing on mature products, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, warranty claims, and unfavorable product mix, partially offset by product cost improvements and favorable foreign currency exchange rate changes.

Non-GAAP gross profit for the second quarter of 2019 was $78.1 million, compared with $74.2 million for the second quarter of 2018, an increase of $3.9 million or 5.3%. Non-GAAP gross profit margin (non-GAAP gross profit as a percentage of revenues) for the second quarter of 2019 was 38.1%, compared with 39.4% for the second quarter of 2018. The non-GAAP gross profit increase was primarily due to higher shipping volumes, product cost improvements, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, warranty claims, and unfavorable product mix. The non-GAAP gross profit margin decrease was primarily driven by lower average pricing on mature products, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, warranty claims, and unfavorable product mix, partially offset by product cost improvements and favorable foreign currency exchange rate changes.

Research and Development Expenses

Research and development expenses for the second quarter of 2019 were $25.0 million, compared with $25.4 million for the second quarter of 2018, a decrease of $0.4 million or 1.6%. Research and development expenses as a percentage of revenues for the second quarter of 2019 and 2018 were 12.2% and 13.5%, respectively. The decrease in research and development expenses was primarily driven by lower compensation as a result of actions taken to optimize the Audio segment workforce. The decrease as a percentage of revenues was primarily driven by increased revenues.

Selling and Administrative Expenses

Selling and administrative expenses for the second quarter of 2019 were $38.9 million, compared with $37.1 million for the second quarter of 2018, an increase of $1.8 million or 4.9%. Selling and administrative expenses as a percentage of revenues for the second quarter of 2019 and 2018 were 19.0% and 19.7%, respectively. The increase in selling and administrative expenses was primarily driven by expenses related to shareholder activism and our acquisition of DITF in January 2019, partially offset by lower incentive compensation expense. The decrease as a percentage of revenues was primarily driven by increased revenues.

Interest Expense, net

Interest expense for the second quarter of 2019 was $3.6 million, compared with $4.1 million for the second quarter of 2018, a decrease of $0.5 million. The decrease in interest expense is primarily due to lower outstanding borrowings. For additional information on borrowings and interest expense, refer to Note 11. Borrowings to our Consolidated Financial Statements.


31

Table of Contents


Provision for Income Taxes and Non-GAAP Provision for Income Taxes

The effective tax rate ("ETR") from continuing operations for the second quarter of 2019 was a 36.6% provision, compared with a 24.1% provision for the second quarter of 2018. The change in the ETR was primarily due to the mix of earnings and losses by taxing jurisdictions.

The non-GAAP ETR from continuing operations for the second quarter of 2019 was a 14.5% provision, compared with a 11.1% provision for the second quarter of 2018. The non-GAAP ETR from continuing operations for the second quarter of 2019 was impacted by a net discrete benefit totaling $0.4 million. The non-GAAP ETR from continuing operations for the second quarter of 2018 was impacted by net discrete expense totaling $0.3 million, primarily related to the change in the Company's uncertain tax positions. Absent the discrete items, the non-GAAP ETR from continuing operations for the second quarter of 2019 and 2018 was a 16.1% provision and a 9.5% provision, respectively. The change in the non-GAAP ETR was due to the mix of earnings and losses by taxing jurisdictions.

The ETR and non-GAAP ETR deviate from the statutory U.S. federal income tax rate, mainly due to the taxing jurisdictions where we generate taxable income or loss, the favorable impact of our significant tax holidays in Malaysia, and judgments as to the realizability of our deferred tax assets. A significant portion of our pre-tax income is subject to a lower tax rate as a result of our Malaysian tax holidays, subject to our annual satisfaction of certain conditions we expect to continue to satisfy. Unless extended or renegotiated, our existing significant tax holiday in Malaysia will expire on December 31, 2021. For additional information on these tax holidays, refer to Note 13. Income Taxes to our Consolidated Financial Statements.

Earnings from Continuing Operations

Earnings from continuing operations for the second quarter of 2019 was $5.9 million, compared with $4.4 million for the second quarter of 2018, an increase of $1.5 million. The increase is primarily due to higher gross profit, partially offset by increased selling and administrative expenses.

Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes

Earnings before interest and income taxes ("EBIT") from continuing operations for the second quarter of 2019 was $12.9 million, compared with $9.9 million for the second quarter of 2018, an increase of $3.0 million. EBIT margin (EBIT from continuing operations as a percentage of revenues) for the second quarter of 2019 was 6.3%, compared with 5.3% for the second quarter of 2018. The increases in EBIT and EBIT margin were primarily due to higher gross profit, partially offset by increased selling and administrative expenses.

Adjusted earnings before interest and income taxes ("Adjusted EBIT") from continuing operations for the second quarter of 2019 was $26.1 million, compared with $21.4 million for the second quarter of 2018, an increase of $4.7 million. Adjusted EBIT margin (adjusted EBIT from continuing operations as a percentage of revenues) for the second quarter of 2019 was 12.7%, compared with 11.4% for the second quarter of 2018. The increases in Adjusted EBIT and Adjusted EBIT margin were primarily due to higher non-GAAP gross profit and lower non-GAAP operating expenses.

Earnings from Discontinued Operations, net

There was no impact related to the sale of our Timing Device Business on November 28, 2017 in the second quarter of 2019, compared with earnings of $0.2 million for the second quarter of 2018.

Diluted Earnings per Share from Continuing Operations and Non-GAAP Diluted Earnings per Share from Continuing Operations

Diluted earnings per share from continuing operations was $0.06 for the second quarter of 2019, compared with $0.05 for the second quarter of 2018. The increase in diluted earnings per share was primarily due to higher EBIT, partially offset by a higher provision for income taxes.

Non-GAAP diluted earnings per share from continuing operations was $0.22 for the second quarter of 2019, compared with $0.18 for the second quarter of 2018. The increase in Non-GAAP diluted earnings per share was mainly driven by higher adjusted EBIT, partially offset by a higher Non-GAAP provision for income taxes.

32

Table of Contents



Results of Operations for the Six Months Ended June 30, 2019 compared with the Six Months Ended June 30, 2018

 
 
Six Months Ended June 30,
(in millions, except per share amounts)
 
2019
 
2018
Revenues
 
$
385.0

 
$
366.9

 
 
 
 
 
Gross profit
 
$
144.9

 
$
138.5

Non-GAAP gross profit
 
$
148.0

 
$
140.9

 
 
 
 
 
Earnings from continuing operations before interest and income taxes
 
$
16.3

 
$
14.3

Adjusted earnings from continuing operations before interest and income taxes
 
$
42.8

 
$
36.1

 
 
 
 
 
Provision for income taxes
 
$
6.0

 
$
2.2

Non-GAAP provision for income taxes
 
$
6.6

 
$
3.6

 
 
 
 
 
Earnings from continuing operations
 
$
3.2

 
$
4.0

Non-GAAP net earnings from continuing operations
 
$
32.5

 
$
27.5

 
 
 
 
 
Earnings per share from continuing operations - diluted
 
$
0.03

 
$
0.04

Non-GAAP diluted earnings per share from continuing operations
 
$
0.34

 
$
0.30


Revenues

Revenues for the six months ended June 30, 2019 were $385.0 million, compared with $366.9 million for the six months ended June 30, 2018, an increase of $18.1 million or 4.9%. PD revenues increased $17.3 million primarily due to higher shipments to the telecommunications and medical markets, increased revenues related to our acquisition of DITF in January 2019, and the benefit of higher pricing. Audio revenues increased $0.8 million due to higher demand of MEMS microphones for Ear and IoT applications and higher shipments of MEMS microphones used in handset applications to our key Chinese OEMs. The increases were partially offset by lower shipments of MEMS microphones to our largest customer as a result of their mobile handset inventory correction earlier in 2019. In addition, shipments of MEMS microphones used in mobile handset applications decreased as a result of lower demand from key Korean and Taiwanese OEMs. Audio revenues were also impacted by lower average pricing on mature products.

Cost of Goods Sold

COGS for the six months ended June 30, 2019 was $239.2 million, compared with $228.3 million for the six months ended June 30, 2018, an increase of $10.9 million or 4.8%. This increase was primarily the result of higher shipping volume, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, and warranty claims, partially offset by product cost improvements and favorable foreign currency exchange rate changes.

Restructuring Charges

During the six months ended June 30, 2019, we recorded restructuring charges of $0.9 million within Gross Profit, primarily for actions associated with transferring certain operations of capacitors manufacturing to other existing facilities in order to further optimize operations in the PD segment. The Company also recorded restructuring charges of $1.9 million within Operating expenses, primarily for actions associated with rationalizing the Audio segment workforce.

During the six months ended June 30, 2018, we recorded total restructuring charges of $0.1 within Gross Profit, primarily for actions associated with optimizing operations in the PD segment. The Company also recorded restructuring charges of $0.9 million within Operating expenses, primarily for actions associated with reorganizing the Audio segment research and development workforce.


33

Table of Contents


Gross Profit and Non-GAAP Gross Profit

Gross profit for the six months ended June 30, 2019 was $144.9 million, compared with $138.5 million for the six months ended June 30, 2018, an increase of $6.4 million or 4.6%. Gross profit margin for the second quarter of 2019 was 37.6%, compared with 37.7% for the six months ended June 30, 2018. The gross profit increase was primarily due to higher shipping volumes, product cost improvements, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, and warranty claims. The gross profit margin remained relatively flat driven by lower average pricing on mature products, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, and warranty claims, partially offset by product cost improvements and favorable foreign currency exchange rate changes.

Non-GAAP gross profit for the six months ended June 30, 2019 was $148.0 million, compared with $140.9 million for the six months ended June 30, 2018, an increase of $7.1 million or 5.0%. Non-GAAP gross profit margin for the six months ended June 30, 2019 and 2018 was 38.4%. The non-GAAP gross profit increase was primarily due to higher shipping volumes, product cost improvements, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, and warranty claims. The non-GAAP gross profit margin remained flat driven by lower average pricing on mature products, personnel and factory overhead increases in PD to support higher production volumes and manufacturing capacity, and warranty claims, partially offset by product cost improvements and favorable foreign currency exchange rate changes.

Research and Development Expenses

Research and development expenses for the six months ended June 30, 2019 were $49.7 million, compared with $50.2 million for the six months ended June 30, 2018, a decrease of $0.5 million or 1.0%. Research and development expenses as a percentage of revenues for the six months ended June 30, 2019 and 2018 were 12.9% and 13.7%, respectively. The decrease in research and development expenses was primarily driven by lower compensation as a result of actions taken to optimize the Audio segment workforce. The decrease as a percentage of revenues was primarily driven by increased revenues.

Selling and Administrative Expenses

Selling and administrative expenses for the six months ended June 30, 2019 were $76.5 million, compared with $72.9 million for the six months ended June 30, 2018, an increase of $3.6 million or 4.9%. Selling and administrative expenses as a percentage of revenues for the six months ended June 30, 2019 and 2018 were 19.9%. The increase in selling and administrative expenses was primarily driven by expenses related to shareholder activism and our acquisition of DITF in January 2019, partially offset by lower incentive compensation expenses.

Interest Expense, net

Interest expense for the six months ended June 30, 2019 was $7.1 million, compared with $8.1 million for the six months ended June 30, 2018, a decrease of $1.0 million. The decrease in interest expense is primarily due to lower outstanding borrowings. For additional information on borrowings and interest expense, refer to Note 11. Borrowings to our Consolidated Financial Statements.

Provision for Income Taxes and Non-GAAP Provision for Income Taxes

The ETR from continuing operations for the six months ended June 30, 2019 was a 65.2% provision, compared with a 35.5% provision for the six months ended June 30, 2018. The change in the ETR was primarily due to the mix of earnings and losses by taxing jurisdictions.

The non-GAAP ETR from continuing operations for the six months ended June 30, 2019 was a 16.9% provision, compared with a 11.6% provision for the six months ended June 30, 2018. The non-GAAP ETR from continuing operations for the six months ended June 30, 2019 was impacted by net discrete expense totaling $0.8 million, primarily related to a change in the Company’s uncertain tax positions. The non-GAAP ETR from continuing operations for the six months ended June 30, 2018 was impacted by net discrete expense totaling $0.3 million, primarily related to the change in the Company's uncertain tax positions. Absent the discrete items, the non-GAAP ETR from continuing operations for the six months ended June 30, 2019 was a 14.8% provision, compared to a 10.6% provision for the six months ended June 30, 2018. The change in the non-GAAP ETR was due to the mix of earnings and losses by taxing jurisdictions.

34

Table of Contents



The ETR and non-GAAP ETR deviate from the statutory U.S. federal income tax rate, mainly due to the taxing jurisdictions where we generate taxable income or loss, the favorable impact of our significant tax holidays in Malaysia, and judgments as to the realizability of our deferred tax assets. A significant portion of our pre-tax income is subject to a lower tax rate as a result of our Malaysian tax holidays, subject to our annual satisfaction of certain conditions we expect to continue to satisfy. Unless extended or renegotiated, our existing significant tax holiday in Malaysia will expire on December 31, 2021. For additional information on these tax holidays, refer to Note 13. Income Taxes to our Consolidated Financial Statements.

Earnings from Continuing Operations

Earnings from continuing operations for the six months ended June 30, 2019 was $3.2 million, compared with $4.0 million for the six months ended June 30, 2018, a decrease of $0.8 million. The decrease is primarily due to increased operating expenses and a higher provision for income taxes, partially offset by higher gross profit and lower interest expense.

Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes

EBIT from continuing operations for the six months ended June 30, 2019 was $16.3 million, compared with $14.3 million for the six months ended June 30, 2018, an increase of $2.0 million. EBIT margin for the six months ended June 30, 2019 was 4.2%, compared with 3.9% for the six months ended June 30, 2018. The increases in EBIT and EBIT margin were primarily due to higher gross profit, partially offset by increased operating expenses.

Adjusted EBIT from continuing operations for the six months ended June 30, 2019 was $42.8 million, compared with $36.1 million for the six months ended June 30, 2018, an increase of $6.7 million. Adjusted EBIT margin for the six months ended June 30, 2019 was 11.1%, compared with 9.8% for the six months ended June 30, 2018. The increases in Adjusted EBIT and Adjusted EBIT margin were primarily due to higher non-GAAP gross profit.

Earnings from Discontinued Operations, net

There was no impact related to the sale of our Timing Device Business in the six months ended June 30, 2019, compared with earnings of $0.3 million for the six months ended June 30, 2018.

Diluted Earnings per Share from Continuing Operations and Non-GAAP Diluted Earnings per Share from Continuing Operations

Diluted earnings per share from continuing operations was $0.03 for the six months ended June 30, 2019, compared with $0.04 for the six months ended June 30, 2018. The change was mainly driven by a higher provision for income taxes, partially offset by higher EBIT.

Non-GAAP diluted earnings per share from continuing operations was $0.34 for the six months ended June 30, 2019, compared with $0.30 for the six months ended June 30, 2018. The increase in Non-GAAP diluted earnings per share was mainly driven by higher adjusted EBIT, partially offset by a higher Non-GAAP provision for income taxes.


35

Table of Contents


Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures (1) 
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
(in millions, except share and per share amounts)
 
2019
 
2018
 
2019
 
2018
Gross profit
 
$
76.4

 
$
73.2

 
$
144.9

 
$
138.5

Stock-based compensation expense
 
0.4

 
0.4

 
0.8

 
0.8

Restructuring charges
 
0.4

 
0.1

 
0.9

 
0.1

Production transfer costs (2)
 
0.9

 
0.5

 
1.4

 
1.3

Other (3)
 

 

 

 
0.2

Non-GAAP gross profit
 
$
78.1

 
$
74.2

 
$
148.0

 
$
140.9

 
 
 
 
 
 
 
 
 
Earnings from continuing operations
 
$
5.9

 
$
4.4

 
$
3.2

 
$
4.0

Interest expense, net
 
3.6

 
4.1

 
7.1

 
8.1

Provision for income taxes
 
3.4

 
1.4

 
6.0

 
2.2

Earnings from continuing operations before interest and income taxes
 
12.9

 
9.9

 
16.3

 
14.3

Stock-based compensation expense
 
7.3

 
7.3

 
14.0

 
14.3

Intangibles amortization expense
 
1.7

 
1.6

 
3.5

 
3.2

Restructuring charges
 
0.5

 
0.6

 
2.8

 
1.0

Production transfer costs (2)
 
0.9

 
0.7

 
1.4

 
1.7

Other (3)
 
2.8

 
1.3

 
4.8

 
1.6

Adjusted earnings from continuing operations before interest and income taxes
 
$
26.1

 
$
21.4

 
$
42.8

 
$
36.1

 
 
 
 
 
 
 
 
 
Interest expense, net
 
$
3.6

 
$
4.1

 
$
7.1

 
$
8.1

Interest expense, net non-GAAP reconciling adjustments (4)
 
1.7

 
1.6

 
3.4

 
3.1

Non-GAAP interest expense
 
$
1.9

 
$
2.5

 
$
3.7

 
$
5.0

 
 
 
 
 
 
 
 
 
Provision for income taxes
 
$
3.4

 
$
1.4

 
$
6.0

 
$
2.2

Income tax effects of non-GAAP reconciling adjustments (5)
 
0.1

 
0.7

 
0.6

 
1.4

Non-GAAP provision for income taxes
 
$
3.5

 
$
2.1

 
$
6.6

 
$
3.6

 
 
 
 
 
 
 
 
 
Earnings from continuing operations
 
$
5.9

 
$
4.4

 
$
3.2

 
$
4.0

Non-GAAP reconciling adjustments (6)
 
13.2

 
11.5

 
26.5

 
21.8

Interest expense, net non-GAAP reconciling adjustments (4)
 
1.7

 
1.6

 
3.4

 
3.1

Income tax effects of non-GAAP reconciling adjustments (5)
 
0.1

 
0.7

 
0.6

 
1.4

Non-GAAP net earnings from continuing operations
 
$
20.7

 
$
16.8

 
$
32.5

 
$
27.5

 
 
 
 
 
 
 
 
 
Diluted earnings per share from continuing operations
 
$
0.06

 
$
0.05

 
$
0.03

 
$
0.04

Earnings per share non-GAAP reconciling adjustment
 
0.16

 
0.13

 
0.31

 
0.26

Non-GAAP diluted earnings per share from continuing operations
 
$
0.22

 
$
0.18

 
$
0.34

 
$
0.30

 
 
 
 
 
 
 
 
 
Diluted average shares outstanding
 
92,507,279

 
90,731,760

 
92,184,274

 
90,718,298

Non-GAAP adjustment (7)
 
2,215,158

 
2,481,654

 
2,079,695

 
2,259,442

Non-GAAP diluted average shares outstanding (7)
 
94,722,437

 
93,213,414

 
94,263,969

 
92,977,740



36

Table of Contents


(1) In addition to the GAAP financial measures included herein, Knowles has presented certain non-GAAP financial measures that exclude certain amounts that are included in the most directly comparable GAAP measures. Knowles believes that non-GAAP measures are useful as supplements to its GAAP results of operations to evaluate certain aspects of its operations and financial performance, and its management team primarily focuses on non-GAAP items in evaluating Knowles' performance for business planning purposes. Knowles also believes that these measures assist it with comparing its performance between various reporting periods on a consistent basis, as these measures remove from operating results the impact of items that, in Knowles' opinion, do not reflect its core operating performance. Knowles believes that its presentation of non-GAAP financial measures is useful because it provides investors and securities analysts with the same information that Knowles uses internally for purposes of assessing its core operating performance.
(2) Production transfer costs represent duplicate costs incurred to migrate manufacturing to facilities primarily in Asia. These amounts are included in the corresponding Gross profit and Earnings from continuing operations before interest and income taxes for each period presented.
(3) 
In 2019, Other expenses of $4.1 million represent expenses related to shareholder activism and the remaining Other expenses relate to the acquisition of DITF by the PD segment. In 2018, Other expenses in Gross profit and Operating expenses represent expenses related to acquisitions and the remaining Other expenses represent an adjustment to pre-spin-off pension obligations.
(4) 
Under GAAP, certain convertible debt instruments that may be settled in cash (or other assets) upon conversion are required to be separately accounted for as liability (debt) and equity (conversion option) components of the instrument in a manner that reflects the issuer’s nonconvertible debt borrowing rate. Accordingly, for GAAP purposes we are required to recognize imputed interest expense on the Company’s $172.5 million of convertible senior notes due 2021 that were issued in a private placement in May 2016. The imputed interest rate is 8.12% for the convertible notes due 2021, while the actual coupon interest rate of the notes was 3.25%. The difference between the imputed interest expense and the coupon interest expense is excluded from management’s assessment of the Company’s operating performance because management believes that this non-cash expense is not indicative of its core, ongoing operating performance.
(5) 
Income tax effects of non-GAAP reconciling adjustments are calculated using the applicable tax rates in the jurisdictions of the underlying adjustments. Adjustments are also made to exclude certain impacts of the Tax Reform Act.
(6) 
The non-GAAP reconciling adjustments are those adjustments made to reconcile Earnings from continuing operations before interest and income taxes to Adjusted earnings from continuing operations before interest and income taxes.
(7) 
The number of shares used in the diluted per share calculations on a non-GAAP basis excludes the impact of stock-based compensation expense expected to be incurred in future periods and not yet recognized in the financial statements, which would otherwise be assumed to be used to repurchase shares under the GAAP treasury stock method.


37

Table of Contents


Segment Results of Operations for the Three Months Ended June 30, 2019 compared with the Three Months Ended June 30, 2018

The following is a summary of the results of operations of our two reportable segments: Audio and PD.

See Note 17. Segment Information to the Consolidated Financial Statements for (i) a reconciliation of segment revenues to our consolidated revenues and (ii) a reconciliation of segment earnings from continuing operations before interest and income taxes to our consolidated net earnings from continuing operations.

Audio
 
 
Three Months Ended June 30,
(in millions)
 
2019
 
Percent of Revenues
 
2018
 
Percent of Revenues
Revenues
 
$
159.9

 

 
$
151.8

 

 
 
 
 
 
 
 
 
 
Operating earnings
 
$
21.2

 
13.3%
 
$
17.1

 
11.3%
Other income, net
 

 
 
 
(0.2
)
 
 
Earnings from continuing operations before interest and income taxes
 
$
21.2

 
13.3%
 
$
17.3

 
11.4%
Stock-based compensation expense
 
4.0

 
 
 
3.6

 
 
Intangibles amortization expense
 
1.1

 
 
 
1.1

 
 
Restructuring charges
 
0.1

 
 
 
0.5

 
 
Production transfer costs (1)
 

 
 
 
0.2

 
 
Adjusted earnings from continuing operations before interest and income taxes
 
$
26.4

 
16.5%
 
$
22.7

 
15.0%
 
 
 
 
 
 
 
 
 
(1) Production transfer costs represent duplicate costs incurred to migrate manufacturing to existing facilities in Asia. These amounts are included in earnings from continuing operations before interest and income taxes for each period presented.

Revenues

Revenues were $159.9 million for the second quarter of 2019, compared with $151.8 million for the second quarter of 2018, an increase of $8.1 million or 5.3%. Revenues increased primarily due to higher demand of MEMS microphones for Ear and IoT applications. In addition, shipments of MEMS microphones used in handset applications increased to our largest customer and a key Korean OEM, partially offset by lower demand from key Taiwanese and Chinese OEMs. Revenues were also impacted by lower average pricing on mature products.

Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes

EBIT was $21.2 million for the second quarter of 2019, compared with $17.3 million for the second quarter of 2018, an increase of $3.9 million. EBIT margin for the second quarter of 2019 was 13.3%, compared to 11.4% for the second quarter of 2018. The increases were primarily driven by higher gross profit, lower incentive compensation expense, and reduced research and development expenses. The gross profit increase was primarily due to higher shipments, product cost improvements, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products, warranty claims, and unfavorable product mix.

Adjusted EBIT was $26.4 million for the second quarter of 2019, compared with $22.7 million for the second quarter of 2018, an increase of $3.7 million. Adjusted EBIT margin for the second quarter of 2019 was 16.5%, compared to 15.0% for the second quarter of 2018. The increases were primarily driven by higher gross profit, lower incentive compensation expense, and reduced research and development expenses. The gross profit increase was primarily due to higher shipments, product cost improvements, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products, warranty claims, and unfavorable product mix.


38



Precision Devices
 
 
Three Months Ended June 30,
(in millions)
 
2019
 
Percent of Revenues
 
2018
 
Percent of Revenues
Revenues
 
$
45.3

 
 
 
$
36.6

 
 
 
 
 
 
 
 
 
 
 
Operating earnings
 
$
8.0

 
17.7%
 
$
7.1

 
19.4%
Other (income) expense, net
 
(0.2
)
 
 
 
0.7

 
 
Earnings from continuing operations before interest and income taxes
 
$
8.2

 
18.1%
 
$
6.4

 
17.5%
Stock-based compensation expense
 
0.4

 
 
 
0.2

 
 
Intangibles amortization expense
 
0.6

 
 
 
0.5

 
 
Restructuring charges
 
0.4

 
 
 
0.1

 
 
Production transfer costs (1)
 
0.9

 
 
 
0.5

 
 
Other (2)
 

 
 
 
1.3

 
 
Adjusted earnings from continuing operations before interest and income taxes
 
$
10.5

 
23.2%
 
$
9.0

 
24.6%
 
(1) Production transfer costs represent duplicate costs incurred to migrate manufacturing to existing facilities. These amounts are included in earnings from continuing operations before interest and income taxes for each period presented.
(2) In 2018, Other represents an adjustment to pre-spin-off pension obligations.

Revenues

Revenues were $45.3 million for the second quarter of 2019, compared with $36.6 million for the second quarter of 2018, an increase of $8.7 million or 23.8%. Revenues increased primarily due to higher shipments to the medical and telecommunications markets, increased revenues related to our acquisition of DITF in January 2019, and the benefit of higher pricing.

Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes

EBIT was $8.2 million for the second quarter of 2019, compared with $6.4 million for the second quarter of 2018, an increase of $1.8 million. EBIT margin for the second quarter of 2019 was 18.1%, compared to 17.5% for the second quarter of 2018. The increases were primarily driven by higher gross profit as a result of increased shipments and the benefits of higher pricing, partially offset by personnel and factory overhead increases to support higher production volumes and manufacturing capacity.

Adjusted EBIT was $10.5 million for the second quarter of 2019, compared with $9.0 million for the second quarter of 2018, an increase of $1.5 million. Adjusted EBIT margin for the second quarter of 2019 was 23.2%, compared with 24.6% for the second quarter of 2018. The increase in adjusted EBIT was primarily driven by higher gross profit as a result of increased shipments and the benefits of higher pricing, partially offset by personnel and factory overhead increases to support higher production volumes and manufacturing capacity. The decrease in adjusted EBIT margin was primarily due to lower gross margins as a result of adding production personnel to support our expansion of production capabilities and unfavorable product mix, partially offset by the benefits of higher pricing.

39


Segment Results of Operations for the Six Months Ended June 30, 2019 compared with the Six Months Ended June 30, 2018

Audio
 
 
Six Months Ended June 30,
(in millions)
 
2019
 
Percent of Revenues
 
2018
 
Percent of Revenues
Revenues
 
$
299.0

 

 
$
298.2

 

 
 
 
 
 
 
 
 
 
Operating earnings
 
$
33.0

 
11.0%
 
$
29.3

 
9.8%
Other income, net
 

 
 
 
(0.3
)
 
 
Earnings from continuing operations before interest and income taxes
 
$
33.0

 
11.0%
 
$
29.6

 
9.9%
Stock-based compensation expense
 
7.6

 
 
 
7.0

 
 
Intangibles amortization expense
 
2.3

 
 
 
2.3

 
 
Restructuring charges
 
1.9

 
 
 
0.8

 
 
Production transfer costs (1)
 

 
 
 
0.9

 
 
Adjusted earnings from continuing operations before interest and income taxes
 
$
44.8

 
15.0%
 
$
40.6

 
13.6%
 
 
 
 
 
 
 
 
 
(1) Production transfer costs represent duplicate costs incurred to migrate manufacturing to existing facilities in Asia. These amounts are included in earnings from continuing operations before interest and income taxes for each period presented.

Revenues

Revenues were $299.0 million for the six months ended June 30, 2019, compared with $298.2 million for the six months ended June 30, 2018, an increase of $0.8 million or 0.3%. Revenues increased primarily due to higher demand of MEMS microphones for Ear and IoT applications and higher shipments of MEMS microphones used in handset applications to our key Chinese OEMs. The increases were partially offset by lower shipments of MEMS microphones to our largest customer as a result of their handset inventory correction earlier in 2019. In addition, shipments of MEMS microphones used in handset applications decreased as a result of lower demand from key Korean and Taiwanese OEMs. Revenues were also impacted by lower average pricing on mature products.

Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes

EBIT was $33.0 million for the six months ended June 30, 2019, compared with $29.6 million for the six months ended June 30, 2018, an increase of $3.4 million. EBIT margin for the six months ended June 30, 2019 was 11.0%, compared to 9.9% for the six months ended June 30, 2018. The increases were primarily driven by higher gross profit and lower incentive compensation expense. The gross profit increase was primarily due to higher shipments, product cost improvements, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products and warranty claims.

Adjusted EBIT was $44.8 million for the six months ended June 30, 2019, compared with $40.6 million for the six months ended June 30, 2018, an increase of $4.2 million. Adjusted EBIT margin for the six months ended June 30, 2019 was 15.0%, compared to 13.6% for the six months ended June 30, 2018. The increases were primarily driven by higher gross profit and lower incentive compensation expense. The gross profit increase was primarily due to higher shipments, product cost improvements, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products and warranty claims.


40


Precision Devices
 
 
Six Months Ended June 30,
(in millions)
 
2019
 
Percent of Revenues
 
2018
 
Percent of Revenues
Revenues
 
$
86.0

 
 
 
$
68.7

 
 
 
 
 
 
 
 
 
 
 
Operating earnings
 
$
15.4

 
17.9%
 
$
13.1

 
19.1%
Other (income) expense, net
 
(0.3
)
 
 
 
0.5

 
 
Earnings from continuing operations before interest and income taxes
 
$
15.7

 
18.3%
 
$
12.6

 
18.3%
Stock-based compensation expense
 
0.7

 
 
 
0.4

 
 
Intangibles amortization expense
 
1.2

 
 
 
0.9

 
 
Restructuring charges
 
0.7

 
 
 
0.2

 
 
Production transfer costs (1)
 
1.4

 
 
 
0.8

 
 
Other (2)
 
0.5

 
 
 
1.5

 
 
Adjusted earnings from continuing operations before interest and income taxes
 
$
20.2

 
23.5%
 
$
16.4

 
23.9%
 
(1) Production transfer costs represent duplicate costs incurred to migrate manufacturing to existing facilities. These amounts are included in earnings from continuing operations before interest and income taxes for each period presented.
(2) In 2019, Other represents expenses related to the acquisition of DITF. In 2018, Other represents expenses related to the acquisition of Compex Corporation and an adjustment to pre-spin-off pension obligations.

Revenues

Revenues were $86.0 million for the six months ended June 30, 2019, compared with $68.7 million for the six months ended June 30, 2018, an increase of $17.3 million or 25.2%. Revenues increased primarily due to higher shipments to the telecommunications and medical markets, increased revenues related to our acquisition of DITF in January 2019, and the benefit of higher pricing.

Earnings and Adjusted Earnings from Continuing Operations Before Interest and Income Taxes

EBIT was $15.7 million for the six months ended June 30, 2019, compared with $12.6 million for the six months ended June 30, 2018, an increase of $3.1 million. EBIT margin for the six months ended June 30, 2019 and 2018 was 18.3%. The increase in EBIT was primarily driven by higher gross profit as a result of increased shipments and the benefits of our higher pricing, partially offset by personnel and factory overhead increases to support higher production volumes and manufacturing capacity. Despite an increase in EBIT, our EBIT margin remained flat driven by lower gross margins as a result of adding production personnel to support growth and unfavorable product mix, partially offset by the benefits of higher pricing.

Adjusted EBIT was $20.2 million for the six months ended June 30, 2019, compared with $16.4 million for the six months ended June 30, 2018, an increase of $3.8 million. Adjusted EBIT margin for the six months ended June 30, 2019 was 23.5%, compared with 23.9% for the six months ended June 30, 2018. The increase in adjusted EBIT was primarily driven by higher gross profit as a result of increased shipments and the benefits of our higher pricing, partially offset by personnel and factory overhead increases to support higher production volumes and manufacturing capacity. Despite an increase in adjusted EBIT, our adjusted EBIT margin decreased driven by lower gross margins as a result of adding production personnel to support growth and unfavorable product mix, partially offset by the benefits of higher pricing.


41


Liquidity and Capital Resources

Historically, we have generated and expect to continue to generate positive cash flow from operations. Our ability to fund our operations and capital needs will depend on our ongoing ability to generate cash from operations and access to capital markets. We believe that our future cash flow from operations and access to capital markets will provide adequate resources to fund our working capital needs, dividends (if any), capital expenditures, and strategic investments. We have secured a revolving line of credit in the United States from a syndicate of commercial banks to provide additional liquidity. Furthermore, if we were to require additional cash above and beyond our cash on the balance sheet, the free cash flow generated by the business, and availability under our revolving credit facility, we would most likely seek to raise long-term financing through the U.S. debt or bank markets.

In May 2016, we sold $172.5 million aggregate principal amount of 3.25% convertible senior notes due November 1, 2021 ("the Notes") and concurrently entered into convertible note hedge transactions with respect to our common stock to minimize the potential dilution upon conversion of the Notes. In addition, we entered into warrant transactions whereby we sold warrants to acquire shares of our common stock at a strike price of $21.1050 per share. The Notes will mature in 2021, unless earlier converted. The Notes are unsecured, senior obligations and interest is payable semi-annually in arrears. The Notes will be convertible into cash, shares of our common stock, or a combination thereof, at our election. We have primarily used the net proceeds to reduce borrowings outstanding. For additional information, refer to Note 11. Borrowings to our Consolidated Financial Statements.

On January 19, 2018, the Company acquired substantially all of the assets of Compex Corporation ("Compex") for $18.7 million. The acquired business provides single layer electronic components to the telecommunication, fiber optics, defense, and aerospace markets. See Note 4. Acquisitions to our Consolidated Financial Statements for additional information related to the transaction.

On January 3, 2019, the Company acquired substantially all of the assets of DITF for $11.1 million. The acquired business provides thin film components to the defense, telecommunication, industrial, and medical markets. This acquisition's operations are included in the PD segment. For additional information, refer to Note 4. Acquisitions to our Consolidated Financial Statements.

Our ability to make payments on and to refinance our indebtedness, as well as any debt that we may incur in the future, will depend on our ability in the future to generate cash from operations and financings. Due to the global nature of our operations, a significant portion of our cash is generated and held outside the United States. Our cash and cash equivalents totaled $53.6 million and $73.5 million at June 30, 2019 and December 31, 2018, respectively. Of these amounts, cash held by our non-U.S. operations totaled $50.4 million and $55.3 million as of June 30, 2019 and December 31, 2018, respectively.

To the extent we repatriate these funds to the U.S., we may be required to pay income taxes in certain U.S. states and applicable foreign withholding taxes on those amounts during the period when such repatriation occurs. Management will continue to reassess our need to repatriate the earnings of our foreign subsidiaries.

Cash Flow Summary

Cash flows from operating, investing, and financing activities as reflected in our Consolidated Statements of Cash Flows are summarized in the following table:
 
 
Six Months Ended June 30,
(in millions)
 
2019
 
2018
Net cash flows (used in) provided by:
 
 
 
 
Operating activities
 
$
10.9

 
$
9.3

Investing activities
 
(35.9
)
 
(65.5
)
Financing activities
 
5.0

 
(4.9
)
Effect of exchange rate changes on cash and cash equivalents
 
0.1

 
0.2

Net decrease in cash and cash equivalents
 
$
(19.9
)
 
$
(60.9
)

Operating Activities

Cash provided by operating activities in 2019 increased $1.6 million compared to 2018, primarily from lower payments to settle our other accrued expenses, which includes lower restructuring payments. In addition, there was a net sum of favorable changes in inventories, net and accounts payable, partially offset by the increased payment to settle our annual incentive compensation obligation, which was accrued at a higher level than in the previous year.

42

Table of Contents



Investing Activities

The cash used in investing activities during 2019 was driven by capital expenditures to support our manufacturing capacity expansion and the acquisition of DITF. The cash used in investing activities during 2018 was driven by capital expenditures to support our manufacturing capacity expansion and the acquisition of Compex.

In 2019, we expect capital expenditures to be in the range of 6.0% to 7.0% of revenues.

Financing Activities

Cash provided by financing activities during 2019 is primarily related to the borrowings under our revolving credit facility of $10.0 million, partially offset by the $5.5 million payment of taxes related to net share settlement of equity awards. The cash used in financing activities for 2018 was primarily related to the $4.1 million payment of taxes related to net share settlement of equity awards.

Contingent Obligations

We are involved in various legal proceedings, claims, and investigations arising in the ordinary course of business. Legal contingencies are discussed in Note 16. Commitments and Contingent Liabilities to our Consolidated Financial Statements.

Borrowings

Borrowings (net of debt issuance costs, debt discount, and amortization) consist of the following:
(in millions)
 
June 30, 2019
 
December 31, 2018
3.25% convertible senior notes
 
$
152.9

 
$
149.1

Revolving credit facility
 
19.0

 
9.0

Total
 
171.9

 
158.1

Less current maturities (1)
 

 

Total long-term debt
 
$
171.9

 
$
158.1

(1) There are no required principal payments due under the 3.25% Convertible Senior Notes or the revolving credit facility until maturities in November 2021 and October 2022, respectively.

The interest rate under the New Credit Facility is variable based on LIBOR at the time of the borrowing and the Company’s leverage as measured by a total indebtedness to Consolidated EBITDA ratio. Based upon the Company’s total indebtedness to Consolidated EBITDA ratio, the Company’s borrowing rate could range from LIBOR + 1.25% to LIBOR + 2.25%. In addition, a commitment fee accrues on the average daily unused portion of the New Credit Facility at a rate of 0.20% to 0.35%. At June 30, 2019, we were in compliance with all covenants under these facilities.

Critical Accounting Policies and Estimates

This discussion and analysis of results of operations and financial condition is based on our Consolidated Financial Statements, which have been prepared in conformity with U.S. GAAP. The preparation of these financial statements requires the use of estimates and assumptions related to the reporting of assets, liabilities, revenues, expenses, and related disclosures. In preparing these financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. Estimates are revised periodically. Actual results could differ from these estimates.

The information concerning our critical accounting policies can be found under Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission on February 19, 2019. There are no material changes in our previously reported critical accounting policies.

43

Table of Contents



Recent Accounting Standards

The adoption of recent accounting standards, as included in Note 2. Recent Accounting Standards to our Consolidated Financial Statements, has not had and is not expected to have a significant impact on our revenue, earnings, or liquidity.

44

Table of Contents


Item 3. Quantitative and Qualitative Disclosures About Market Risk

During the six months ended June 30, 2019, there were no material changes to the information on market risk exposure disclosed in our Annual Report on Form 10-K for the year ended December 31, 2018. For a discussion of our exposure to market risk as of December 31, 2018, refer to Item 7A, Quantitative and Qualitative Disclosures about Market Risk, contained in our Annual Report on Form 10-K for the year ended December 31, 2018.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our chief executive officer ("CEO") and chief financial officer ("CFO"), the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report. Based on that evaluation, our CEO and CFO have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting
There has been no change in our internal control over financial reporting that occurred during the second quarter of 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls
Our management, including the CEO and CFO, do not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, will be detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by intentionally falsified documentation, by collusion of two or more individuals within Knowles or third parties, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

For a discussion of contingencies related to legal proceedings, see Note 16. Commitments and Contingent Liabilities to our Consolidated Financial Statements, which is incorporated herein by reference.

Except as otherwise noted above, there have been no material developments in legal proceedings.

Item 1A. Risk Factors

For a discussion of our potential risks and uncertainties, see the information under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018. During the six months ended June 30, 2019, there have been no material changes in our previously reported risk factors.


45

Table of Contents


Item 5. Other Information

At the July 30, 2019 meeting of the Company’s Board of Directors, the Board adopted an amendment to the Company’s Amended and Restated By-Laws eliminating the supermajority vote required for stockholders to amend the by-laws and replacing it with a majority vote standard, consistent with the proposal approved by stockholders at the Company’s annual meeting held on May 31, 2019, and also adopted the Company’s Second Amended and Restated By-Laws integrating that and all other prior amendments to the by-laws. In addition, the Board approved the Company’s Restated Certificate of Incorporation, integrating all prior amendments to the certificate of incorporation. On July 30, 2019, the Company filed the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware, which became effective immediately upon filing. Copies of the Restated Certificate of Incorporation and Second Amended and Restated By-Laws are filed with this Quarterly Report on Form 10-Q as Exhibits 3.1 and 3.2, respectively.


46

Table of Contents


Item 6. Exhibits
3.1
 
 
3.2
 
 
 
 
 
 
 
 
 
 
101
The following financial information from Knowles Corporation's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2019 formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Statements of Earnings (Unaudited) for the three and six months ended June 30, 2019 and 2018, (ii) Consolidated Statements of Comprehensive Earnings (Unaudited) for the three and six months ended June 30, 2019 and 2018, (iii) Consolidated Balance Sheets (Unaudited) as of June 30, 2019 and December 31, 2018, (iv) Consolidated Statements of Stockholders’ Equity (Unaudited) for the six months ended June 30, 2019 and 2018, (v) Consolidated Statements of Cash Flows (Unaudited) for the six months ended June 30, 2019 and 2018, and (vi) the Notes to the Consolidated Financial Statements (Unaudited)


47

Table of Contents


Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
 
KNOWLES CORPORATION
 
 
 
Date:
July 30, 2019
/s/ John S. Anderson
 
 
John S. Anderson
 
 
Senior Vice President & Chief Financial Officer
 
 
(Principal Financial Officer)


48
Exhibit 3.1 RESTATED CERTIFICATE OF INCORPORATION OF KNOWLES CORPORATION Pursuant to Section 245 of the Delaware General Corporation Law Knowles Corporation (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify as follows: (1) The name of the Corporation is Knowles Corporation. The Corporation was originally incorporated under the name Knowles Corporation. The original Certificate of Incorporation of the Corporation was filed with the office of the Secretary of State of the State of Delaware (the “Secretary of State”) on June 12, 2013, amended and restated in its entirety by the Amended and Restated Certificate of Incorporation of the Corporation that was filed with the office of the Secretary of State on February 28, 2014 and as further amended by the Certificates of Amendment that were filed with the office of the Secretary of State on May 3, 2016, May 2, 2018 and June 6, 2019. (2) This Restated Certificate of Incorporation was duly adopted by the Board of Directors of the Corporation (the “Board of Directors”) in accordance with Section 245 of the DGCL. (3) This Restated Certificate of Incorporation restates and integrates, but does not further amend, the provisions of the Certificate of Incorporation of the Corporation as heretofore amended or supplemented, and there is no discrepancy between those provisions and the provisions of this Restated Certificate of Incorporation. (4) The text of the Certificate of Incorporation is restated and integrated to read in its entirety as follows: FIRST: The name of the Corporation is Knowles Corporation (the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, 19801. The name of its registered agent at that address is The Corporation Trust Company. THIRD: The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the General Corporation Law of the State of Delaware (the “DGCL”). FOURTH: (a) Authorized Capital Stock. The total number of shares of stock which the Corporation shall have authority to issue is 410,000,000 shares of capital stock, consisting of (i) 400,000,000 shares of common stock, par value $0.01 per share (the “Common Stock”), and (ii) 10,000,000 shares of preferred stock, par value $0.01 per share (the “Preferred Stock”).


 
(b) Common Stock. The powers, preferences and rights, and the qualifications, limitations and restrictions, of the Common Stock are as follows: (1) Voting. Each stockholder represented at a meeting of the stockholders shall be entitled to cast one (1) vote in person or by proxy for each share of the Common Stock entitled to vote thereat held by such stockholder. (2) No Cumulative Voting. The holders of shares of the Common Stock shall not have cumulative voting rights. (3) Dividends; Stock Splits. Subject to the rights of the holders of Preferred Stock, and subject to any other provisions of this Restated Certificate of Incorporation, as it may be amended from time to time, the holders of shares of the Common Stock shall be entitled to receive ratably such dividends and other distributions in cash, stock or property of the Corporation when, as and if declared thereon by the Board of Directors from time to time out of assets or funds of the Corporation legally available therefor. (4) Liquidation; Dissolution; Winding-Up. In the event of any voluntary or involuntary liquidation, dissolution or winding-up of the Corporation, after payment or provision for payment of the debts and other liabilities of the Corporation, and subject to the rights of the holders of shares of Preferred Stock in respect thereof, the holders of shares of Common Stock shall be entitled to receive all of the remaining assets of the Corporation available for distribution to its stockholders, ratably in proportion to the number of shares of Common Stock held by them. (5) No Preemptive or Subscription Rights. No holder of shares of the Common Stock shall be entitled to preemptive or subscription rights. (c) Preferred Stock. The Board of Directors is hereby expressly authorized to provide for the issuance of all or any shares of the Preferred Stock in one or more classes or series, and to fix for each such class or series such voting powers, full or limited, or no voting powers, and such designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issuance of such class or series, including, without limitation, the authority to provide that any such class or series may be (i) subject to redemption at such time or times and at such price or prices; (ii) entitled to receive dividends (which may be cumulative or non-cumulative) at such rates, on such conditions, and at such times, and payable in preference to, or in such relation to, the dividends payable on any other class or classes or any other series; (iii) entitled to such rights upon the dissolution of, or upon any distribution of the assets of, the Corporation; or (iv) convertible into, or exchangeable for, shares of any other class or classes of stock, or of any other series of the same or any other class or classes of stock, of the Corporation at such price or prices or at such rates of exchange and with such adjustments; all as may be stated in such resolution or resolutions. (d) Power to Sell and Purchase Shares. Subject to the requirements of applicable law, the Corporation shall have the power to issue and sell all or any part of any shares of any 2


 
class of stock herein or hereafter authorized to such persons, and for such consideration, as the Board of Directors shall from time to time, in its discretion, determine, whether or not greater consideration could be received upon the issue or sale of the same number of shares of another class, and as otherwise permitted by law. Subject to the requirements of applicable law, the Corporation shall have the power to purchase any shares of any class of stock herein or hereafter authorized from such persons, and for such consideration, as the Board of Directors shall from time to time, in its discretion, determine, whether or not less consideration could be paid upon the purchase of the same number of shares of another class, and as otherwise permitted by law. FIFTH: The following provisions are inserted for the management of the business and the conduct of the affairs of the Corporation, and for further definition, limitation and regulation of the powers of the Corporation and of its directors and stockholders: (a) The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors. (b) The Board of Directors shall consist of not less than three (3) nor more than fifteen (15) members, the exact number of which shall be fixed from time to time exclusively pursuant to a resolution adopted by the affirmative vote of a majority of the entire Board of Directors, and subject to the rights of the holders of the Preferred Stock, if any, the exact number may be increased or decreased (but not to less than three (3) or more than fifteen (15)). (c) The directors shall, until the annual meeting of stockholders to be held in 2021, be divided into three classes, designated Class I, Class II and Class III. Each class shall consist, as nearly as may be possible, of an equal number of directors. The term of the Class I directors elected at the 2017 annual meeting of stockholders shall terminate on the date of the 2020 annual meeting of stockholders; the term of the Class II directors elected at the 2018 annual meeting of stockholders shall terminate on the date of the 2021 annual meeting of stockholders; and the term of the Class III directors elected at the 2016 annual meeting of stockholders shall terminate on the date of the 2019 annual meeting of stockholders or, in each case, upon such director’s earlier death, resignation or removal. At each succeeding annual meeting of stockholders beginning with the 2019 annual meeting of stockholders, directors standing for election shall be elected annually for one-year terms expiring at the next succeeding annual meeting of stockholders and until his or her respective successor has been duly elected and qualified. (d) Except as provided in Paragraph (e) of this Article FIFTH, directors shall be elected by a majority of the votes cast at the annual meeting of stockholders; provided, however, that, if the number of nominees for director exceeds the number of directors to be elected, directors shall be elected by a plurality of the votes cast. A director shall hold office until the annual meeting of stockholders for the year in which his or her term expires and until his or her successor shall be elected and shall qualify, subject, however, to prior death, resignation, retirement, disqualification or removal from office. Directors need not be stockholders. Elections of directors need not be by written ballot unless the Corporation’s By-Laws so provide. (e) Subject to the terms of any one or more classes or series of the Preferred Stock, any vacancy on the Board of Directors that results from an increase in the number of 3


 
directors or the death, resignation, retirement, disqualification, removal from office or other cause may be filled by a majority of the Board of Directors then in office, in their sole discretion, even if less than a quorum, or by a sole remaining director, in his or her sole discretion. Any director appointed to fill a vacancy on the Corporation’s Board of Directors not resulting from an increase in the number of directors shall have the same remaining term as that of his or her predecessor. In no case will a decrease in the number of directors have the effect of removing or shortening the term of any incumbent director. Prior to and until the time at which the Board of Directors ceases to be classified pursuant to Article FIFTH, Section (c), of this Restated Certificate of Incorporation, except as otherwise required by applicable law and subject to the rights, if any, of the holders of shares of the Preferred Stock then outstanding, any or all of the directors of the Corporation may be removed from office at any time, but only for cause and only by the affirmative vote of the holders of at least a majority of the shares of voting common stock. From and after the time at which the Board of Directors ceases to be classified pursuant to Article FIFTH, Section (c), except as otherwise required by applicable law and subject to the rights, if any, of the holders of shares of Preferred Stock then outstanding, any or all of the directors of the Corporation may be removed from office at any time, with or without cause, by the affirmative vote of the holders of at least a majority of shares of voting common stock. Notwithstanding the foregoing, whenever the holders of any one or more classes or series of the Preferred Stock issued by the Corporation shall have the right, voting separately by class or series, to elect directors at an annual or special meeting of stockholders, the election, term of office, filling of vacancies and other features of such directorships shall be governed by the terms of this Restated Certificate of Incorporation and the resolution or resolutions adopted by the Board of Directors providing for the issuance of such class or series. (f) In addition to the powers and authority hereinbefore or by statute expressly conferred upon them, the directors are hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the Corporation, subject, nevertheless, to the provisions of the DGCL, this Restated Certificate of Incorporation, and any By-Laws adopted by the stockholders; provided, however, that no By-Laws hereafter adopted by the stockholders shall invalidate any prior act of the directors which would have been valid if such By-Laws had not been adopted. SIXTH: No director shall be personally liable to the Corporation or any of its stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL as the same exists or may hereafter be amended. If the DGCL is amended hereafter to authorize the further elimination or limitation of the liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent authorized by the DGCL, as so amended. Any repeal or modification of this Article SIXTH shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification with respect to acts or omissions occurring prior to such repeal or modification. SEVENTH: The Corporation shall indemnify its directors and officers to the fullest extent authorized or permitted by law, as now or hereafter in effect, and such right to indemnification shall continue as to a person who has ceased to be a director or officer of the Corporation and shall inure to the benefit of his or her heirs, executors and personal and legal representatives; provided, however, that, except for proceedings to enforce rights to 4


 
indemnification, the Corporation shall not be obligated to indemnify any director or officer (or his or her heirs, executors or personal or legal representatives) in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized or consented to by the Board of Directors. The right to indemnification conferred by this Article SEVENTH shall include the right to be paid by the Corporation the expenses incurred in defending or otherwise participating in any proceeding in advance of its final disposition, subject to receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the Corporation. The Corporation may, to the extent authorized from time to time by the Board of Directors, provide rights to indemnification and to the advancement of expenses to employees and agents of the Corporation, or to those persons serving at the Corporation’s request as a director, officer, employee or agent of, or in a fiduciary capacity with respect to, another corporation, partnership, joint venture, trust or other enterprise, similar to those conferred in this Article SEVENTH to directors and officers of the Corporation. The Corporation may purchase and maintain insurance on behalf of any person who is or was a director or officer of the Corporation, or is or was a director, officer or employee of the Corporation serving at the request of the Corporation as a director, officer, employee or agent of, or in a fiduciary capacity with respect to, another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the Corporation would have the power or the obligation to indemnify such person against such liability under the provisions of this Article SEVENTH. The rights to indemnification and to the advancement of expenses conferred in this Article SEVENTH shall not be exclusive of any other right which any person may have or hereafter acquire under this Restated Certificate of Incorporation, the By-Laws of the Corporation, any statute, agreement, vote of stockholders or disinterested directors or otherwise. Any repeal or modification of any provision of this Article SEVENTH shall not adversely affect any rights to indemnification and to the advancement of expenses of a director or officer of the Corporation existing at the time of such repeal or modification with respect to any acts or omissions occurring prior to such repeal or modification. EIGHTH: Except as otherwise expressly provided by the terms of any series of Preferred Stock permitting the holders of such series of Preferred Stock to act by written consent, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of stockholders of the Corporation, and the ability of the stockholders to consent in writing to the taking of any action is hereby specifically denied. NINTH: Unless otherwise required by law or the terms of any resolution or resolutions adopted by the Board of Directors providing for the issuance of a class or series of the Preferred Stock, special meetings of stockholders, for any purpose or purposes, may be called by either (i) the Chairman of the Board of Directors or (ii) the Chief Executive Officer of the Corporation, 5


 
and shall be called by the Chief Executive Officer at the request in writing made pursuant to a resolution of a majority of the members of the Board of Directors. The ability of the stockholders to call a special meeting of stockholders is hereby specifically denied. At a special meeting of stockholders, only such business shall be conducted as shall be specified in the notice of meeting (or any supplement thereto). TENTH: Meetings of stockholders may be held within or without the State of Delaware, as the By-Laws may provide. The books of the Corporation may be kept (subject to any provision contained in the DGCL) outside the State of Delaware at such place or places as may be designated from time to time by the Board of Directors or in the By-Laws of the Corporation. ELEVENTH: In furtherance and not in limitation of the powers conferred upon it by the laws of the State of Delaware, the Board of Directors shall have the power, without the assent or vote of the stockholders, to adopt, amend, alter or repeal the Corporation’s By-Laws, except to the extent the By-Laws or this Restated Certificate of Incorporation otherwise provide. The affirmative vote of at least a majority of the entire Board of Directors shall be required to adopt, amend, alter or repeal the Corporation’s By-Laws. The Corporation’s By-Laws also may also be adopted, amended, altered or repealed by the affirmative vote of the holders of a majority of the voting stock then outstanding. TWELFTH: Unless the Board of Directors otherwise determines, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought or purporting to be brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former director or officer of the Corporation to the Corporation or the Corporation’s stockholders, creditors or other constituents, (iii) any action asserting a claim against the Corporation or any current or former director or officer of the Corporation arising pursuant to any provision of the DGCL or the Restated Certificate of Incorporation or By-laws (as either may be amended from time to time), or (iv) any action asserting a claim against the Corporation or any current or former director or officer of the Corporation that relates to the internal affairs or governance of the Corporation and arises under or by virtue of the laws of the State of Delaware; provided, that, if (and only if) the Court of Chancery of the State of Delaware dismisses any such action for lack of subject matter jurisdiction, such action may be brought in another state court sitting in the State of Delaware. THIRTEENTH: The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Restated Certificate of Incorporation in the manner now or hereafter prescribed in this Restated Certificate of Incorporation, the Corporation’s By-Laws or the DGCL, and all rights, preferences and privileges herein conferred upon shareholders are granted subject to such reservation. [Remainder of Page Intentionally Left Blank] 6


 
IN WITNESS WHEREOF, the Corporation has caused this Restated Certificate of Incorporation to be executed on its behalf this 30th day of July, 2019. KNOWLES CORPORATION By: /s/ Robert J. Perna Name: Robert J. Perna Title: Senior Vice President, General Counsel & Secretary


 
EXHIBIT 3.2 SECOND AMENDED AND RESTATED BY-LAWS OF KNOWLES CORPORATION A Delaware Corporation Effective July 30, 2019 1


 
TABLE OF CONTENTS ARTICLE I OFFICES .........................................................................................................................1 Section 1.1 Registered Office .........................................................................................................1 Section 1.2 Other Offices ...............................................................................................................1 ARTICLE II MEETINGS OF STOCKHOLDERS ..............................................................................1 Section 2.1 Place of Meetings ........................................................................................................1 Section 2.2 Annual Meetings ..........................................................................................................1 Section 2.3 Special Meetings ..........................................................................................................1 Section 2.4 Consent of Stockholders in Lieu of Meeting ...............................................................2 Section 2.5 Notice ...........................................................................................................................2 Section 2.6 Adjournments ..............................................................................................................2 Section 2.7 Quorum ........................................................................................................................2 Section 2.8 Voting ..........................................................................................................................3 Section 2.9 Proxies .........................................................................................................................3 Section 2.10 List of Stockholders Entitled to Vote ..........................................................................3 Section 2.11 Record Date .................................................................................................................3 Section 2.12 Stock Ledger ................................................................................................................4 Section 2.13 Conduct of Meetings ....................................................................................................4 Section 2.14 Inspectors of Election ..................................................................................................4 Section 2.15 Nature of Business at Meetings of Stockholders .........................................................4 Section 2.16 Nomination of Directors ..............................................................................................7 ARTICLE III DIRECTORS ................................................................................................................10 Section 3.1 Number and Election of Directors .............................................................................10 Section 3.2 Vacancies ...................................................................................................................10 Section 3.3 Duties and Powers .....................................................................................................10 Section 3.4 Meetings; Notice ........................................................................................................10 Section 3.5 Organization ..............................................................................................................11 Section 3.6 Resignations and Removals of Directors ...................................................................11 Section 3.7 Quorum ......................................................................................................................12 Section 3.8 Actions of the Board by Written Consent ..................................................................12 Section 3.9 Meetings by Means of Conference Telephone ..........................................................12 Section 3.10 Committees ................................................................................................................12 Section 3.11 Executive Committee .................................................................................................13 Section 3.12 Compensation ............................................................................................................13 Section 3.13 Interested Directors ....................................................................................................13 ARTICLE IV OFFICERS ....................................................................................................................14 Section 4.1 General .......................................................................................................................14 Section 4.2 Election ......................................................................................................................14 Section 4.3 Voting Securities Owned by the Corporation ............................................................14 Section 4.4 Chairman of the Board of Directors ..........................................................................15 i


 
Section 4.5 Chief Executive Officer .............................................................................................15 Section 4.6 Vice Presidents ..........................................................................................................15 Section 4.7 Secretary ....................................................................................................................15 Section 4.8 Treasurer ....................................................................................................................15 Section 4.9 Assistant Secretaries ..................................................................................................16 Section 4.10 Assistant Treasurers ...................................................................................................16 Section 4.11 Other Officers ............................................................................................................16 ARTICLE V STOCK ..........................................................................................................................16 Section 5.1 Uncertificated Shares .................................................................................................16 Section 5.2 Dividend Record Date ...............................................................................................17 Section 5.3 Record Owners ..........................................................................................................17 Section 5.4 Transfer and Registry Agents ....................................................................................17 ARTICLE VI NOTICES ......................................................................................................................17 Section 6.1 Notices .......................................................................................................................17 Section 6.2 Waivers of Notice ......................................................................................................17 ARTICLE VII GENERAL PROVISIONS ...........................................................................................18 Section 7.1 Dividends ...................................................................................................................18 Section 7.2 Disbursements ............................................................................................................18 Section 7.3 Fiscal Year .................................................................................................................18 Section 7.4 Corporate Seal ...........................................................................................................18 Section 7.5 Contracts ....................................................................................................................18 ARTICLE VIII INDEMNIFICATION ...................................................................................................18 Section 8.1 Power to Indemnify in Actions, Suits or Proceedings other than Those by or in the Right of the Corporation ............................................................................................18 Section 8.2 Power to Indemnify in Actions, Suits or Proceedings by or in the Right of the Corporation ................................................................................................................19 Section 8.3 Authorization of Indemnification ..............................................................................19 Section 8.4 Good Faith Defined ...................................................................................................20 Section 8.5 Indemnification by a Court ........................................................................................20 Section 8.6 Expenses Payable in Advance ...................................................................................20 Section 8.7 Nonexclusivity of Indemnification and Advancement of Expenses ..........................20 Section 8.8 Insurance ....................................................................................................................21 Section 8.9 Certain Definitions .....................................................................................................21 Section 8.10 Survival of Indemnification and Advancement of Expenses ....................................21 Section 8.11 Limitation on Indemnification ...................................................................................22 Section 8.12 Indemnification of Employees and Agents ................................................................22 Section 8.13 Amendment or Repeal ...............................................................................................22 ARTICLE IX AMENDMENTS ..........................................................................................................22 Section 9.1 Amendments ..............................................................................................................22 ARTICLE X CONSTRUCTION ........................................................................................................22 ii


 
Section 10.1 Construction ...............................................................................................................22 Section 10.2 Entire Board of Directors ...........................................................................................22 iii


 
SECOND AMENDED AND RESTATED BY-LAWS OF KNOWLES CORPORATION (hereinafter called the “Corporation”) ARTICLE I OFFICES Section 1.1 Registered Office. The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 1.2 Other Offices. The Corporation may also have offices at such other places, both within and without the State of Delaware, as the Board of Directors may from time to time determine. ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Place of Meetings. Meetings of the stockholders for the election of directors or for any other purpose shall be held at such time and place, either within or without the State of Delaware, as shall be designated from time to time by the Board of Directors. Section 2.2 Annual Meetings. The Annual Meeting of Stockholders for the election of directors shall be held on such date and at such time as shall be designated from time to time by the Board of Directors. Any other proper business may be transacted at the Annual Meeting of Stockholders. The Board of Directors may postpone, reschedule or cancel any Annual Meeting of Stockholders previously scheduled by the Board. Section 2.3 Special Meetings. Unless otherwise required by law or by the certificate of incorporation of the Corporation, as amended and restated from time to time (the “Certificate of Incorporation”), a Special Meeting of Stockholders, for any purpose or purposes, may be called by either (a) the Chairman of the Board of Directors or (b) the Chief Executive Officer of the Corporation, and shall be called by the Chief Executive Officer at the request in writing or electronic transmission made pursuant to a resolution of a majority of the members of the Board of Directors. Such request shall state the purpose or purposes of the proposed meeting. The ability of the stockholders to call a Special Meeting of Stockholders is hereby specifically denied. At a Special Meeting of Stockholders, only such business shall be conducted as shall be specified in the notice of meeting (or any supplement thereto). The Board of Directors may postpone, reschedule or cancel any Special Meeting of Stockholders previously scheduled by the Board. 1


 
Section 2.4 Consent of Stockholders in Lieu of Meeting. Except as otherwise expressly provided by the terms of any series of preferred stock permitting the holders of such series of preferred stock to act by written consent, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called Annual Meeting of Stockholders or Special Meeting of Stockholders, and the ability of the stockholders to consent in writing to the taking of any action is hereby specifically denied. Section 2.5 Notice. Whenever stockholders are required or permitted to take any action at a meeting, a written notice of the meeting shall be given which shall state the place, date and hour of the meeting, the record date for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to notice of meeting, and, in the case of a Special Meeting, the purpose or purposes for which the meeting is called, and the means of remote communications, if any, by which stockholders and proxy holders may be deemed present in person and vote at such meeting. Unless otherwise required by law, written notice of any meeting shall be given either personally, by mail or electronic transmission, (if permitted under the General Corporation Law of the State of Delaware (“DGCL”)) not less than ten (10) nor more than sixty (60) days before the date of the meeting to each stockholder entitled to notice of and to vote at such meeting. Any stockholder may waive notice of any meeting before or after the meeting. The attendance of a stockholder at any meeting shall constitute a waiver of notice at such meeting, except where the stockholder attends the meeting for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened. Meetings of the stockholders may be held at any time without notice when all of the stockholders entitled to vote thereat are represented in person or by proxy. Section 2.6 Adjournments. Any meeting of the stockholders may be adjourned from time to time to reconvene at the same or some other place by holders of a majority of the voting power of the Corporation’s capital stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy, though less than a quorum, or by any officer entitled to preside at or to act as secretary of such meeting, and notice need not be given of any such adjourned meeting if the time and place thereof, and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting, are announced at the meeting at which the adjournment is taken. At the adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, notice of the adjourned meeting in accordance with the requirements of Section 2.5 shall be given to each stockholder of record entitled to notice of and to vote at the meeting. Section 2.7 Quorum. Unless otherwise required by applicable law or the Certificate of Incorporation, the holders of a majority of the voting power of the Corporation’s capital stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business. Where a separate vote by a class or classes or series is required, a majority of the voting power of the shares of such class or classes or series present in person or represented by proxy shall constitute a quorum entitled to take action with respect to such vote. A quorum, once established, shall not be broken by the withdrawal of enough votes to leave less than a quorum. 2


 
If, however, such quorum shall not be present or represented at any meeting of the stockholders, either the chair of the meeting or the stockholders entitled to vote thereat, present in person or represented by proxy, shall have power to adjourn the meeting from time to time, in the manner provided in Section 2.6, until a quorum shall be present or represented. Section 2.8 Voting. Unless otherwise required by law, the Certificate of Incorporation or these By-Laws, any question brought before any meeting of the stockholders, other than the election of directors, shall be decided by the affirmative vote of the holders of a majority of the total number of votes of the Corporation’s capital stock represented at the meeting and entitled to vote on such question, voting as a single class. Unless otherwise provided in the Certificate of Incorporation, and subject to Section 2.11, each stockholder represented at a meeting of the stockholders shall be entitled to cast one (1) vote for each share of the capital stock entitled to vote thereat held by such stockholder. Such votes may be cast in person or by proxy as provided in Section 2.9. The Board of Directors, in its discretion, or the officer of the Corporation presiding at a meeting of the stockholders, in such officer’s discretion, may require that any votes cast at such meeting shall be cast by written ballot. Shares of stock of the Corporation belonging to the Corporation, or to another corporation a majority of the shares entitled to vote in the election of directors of which are held by the Corporation, shall not be voted at any meeting of stockholders of the Corporation and shall not be counted in the total number of outstanding shares for the purpose of determining whether a quorum is present. Section 2.9 Proxies. Each stockholder entitled to vote at a meeting of the stockholders may authorize another person or persons to act for such stockholder by proxy filed with the Secretary before or at the time of the meeting, but no such proxy shall be voted or acted upon after three (3) years from its date, unless such proxy provides for a longer period. Section 2.10 List of Stockholders Entitled to Vote. The officer of the Corporation who has charge of the stock ledger of the Corporation shall prepare and make, or have prepared and made, at least ten (10) days before every meeting of the stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten (10) days prior to the meeting either (i) at a place within the city where the meeting is to be held, which place shall be specified in the notice of the meeting, or, if not so specified, at the place where the meeting is to be held or (ii) during ordinary business hours, at the principal place of business of the Corporation. If the meeting is to be held at a place, then the list shall also be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present. If the meeting is to be held solely by means of remote communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting. Section 2.11 Record Date. In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of the stockholders or any 3


 
adjournment thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall not be more than sixty (60) nor less than ten (10) days before the date of such meeting. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of the stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of the stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting. Section 2.12 Stock Ledger. The stock ledger of the Corporation shall be the only evidence as to who are the stockholders entitled to examine the stock ledger, the list required by Section 2.10 or the books of the Corporation, or to vote in person or by proxy at any meeting of the stockholders. Section 2.13 Conduct of Meetings. The Board of Directors of the Corporation may adopt by resolution such rules and regulations for the conduct of any meeting of the stockholders as it shall deem appropriate. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the chair of any meeting of the stockholders shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chair, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chair of the meeting, may include, without limitation, the following: (i) the establishment of an agenda or order of business for the meeting; (ii) the determination of when the polls shall open and close for any given matter to be voted on at the meeting; (iii) rules and procedures for maintaining order at the meeting and the safety of those present; (iv) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation, their duly authorized and constituted proxies or such other persons as the chair of the meeting shall determine; (v) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (vi) limitations on the time allotted to questions or comments by participants. Section 2.14 Inspectors of Election. In advance of any meeting of the stockholders, the Board of Directors, by resolution, the Chairman of the Board or the Chief Executive Officer shall appoint one or more inspectors to act at the meeting and make a written report thereof. One or more other persons may be designated as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of the stockholders, the chair of the meeting shall appoint one or more inspectors to act at the meeting. Unless otherwise required by applicable law, inspectors may be officers, employees or agents of the Corporation. Each inspector, before entering upon the discharge of the duties of inspector, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of such inspector’s ability. The inspector shall have the duties prescribed by law and shall take charge of the polls and, when the vote is completed, shall make a certificate of the result of the vote taken and of such other facts as may be required by applicable law. Section 2.15 Nature of Business at Meetings of Stockholders. Only such business may be transacted at an Annual Meeting of Stockholders as is either (a) specified in the notice of 4


 
meeting (or any supplement thereto) given by or at the direction of the Board of Directors (or any duly authorized committee thereof), (b) otherwise properly brought before the Annual Meeting by or at the direction of the Board of Directors (or any duly authorized committee thereof), or (c) otherwise properly brought before the Annual Meeting by any stockholder of the Corporation (i) who is a stockholder of record on the date of the giving of the notice provided for in this Section 2.15 and on the record date for the determination of stockholders entitled to notice of and to vote at such Annual Meeting, (ii) who is entitled to vote at such Annual Meeting and (iii) who complies with the notice procedures set forth in this Section 2.15. Clause (c) of the preceding sentence shall be the exclusive means for a stockholder to bring business before an Annual Meeting (other than matters properly brought under Rule 14a-8 under Securities Exchange Act of 1934, as amended (the “Exchange Act”), or any successor provision of law, and included in the Corporation’s notice of meeting). In addition to any other applicable requirements, for business to be properly brought before an Annual Meeting by a stockholder, such stockholder must have given timely notice thereof in proper written form to the Secretary of the Corporation. To be timely, a stockholder’s notice to the Secretary must be delivered to or be mailed and received at the principal executive offices of the Corporation not later than the close of business on the ninetieth (90th) day nor earlier than the close of business on the one hundred and twentieth (120th) day prior to the anniversary date of the immediately preceding Annual Meeting of Stockholders; provided, however, that in the event that the Annual Meeting is called for a date that is not within thirty (30) days before or after such anniversary date, or in the case of the Corporation’s first Annual Meeting, notice by the stockholder in order to be timely must be so received not later than the close of business on the tenth (10th) day following the day on which such notice of the date of the Annual Meeting was mailed or such public disclosure of the date of the Annual Meeting was made, whichever first occurs. In no event shall the adjournment or postponement of an Annual Meeting, or the public announcement of such an adjournment or postponement, commence a new time period (or extend any time period) for the giving of a stockholder’s notice as described above. To be in proper written form, a stockholder’s notice to the Secretary must set forth the following information: (a) as to each matter such stockholder proposes to bring before the Annual Meeting, a brief description of the business desired to be brought before the Annual Meeting, the reasons for conducting such business at the Annual Meeting, the text of the proposal or business (including the text of any resolutions proposed for consideration and, in the event that such business includes a proposal to amend these By-Laws, the language of the proposed amendment), and (b) as to the stockholder giving notice and the beneficial owner, if any, on whose behalf the proposal is being made, (i) the name and address of such person; (ii) (A) the class or series and number of all shares of stock of the Corporation which are owned, directly or indirectly, beneficially or of record by such person and any affiliates or associates of such person, (B) the name of each nominee holder of shares of all stock of the Corporation owned beneficially but not of record by such person or any affiliates or associates of such person, and the number of such shares of stock of the Corporation held by each such nominee holder, (C) whether and the extent to which any derivative instrument, swap, option, warrant, short interest, hedge or profit interest or other transaction has been entered into by or on behalf of such person, or any affiliates or associates of such person, with respect to stock of the Corporation and (D) whether and the extent to which any other transaction, agreement, 5


 
arrangement or understanding (including any short position or any borrowing or lending of shares of stock of the Corporation) has been made by or on behalf of such person, or any affiliates or associates of such person, the effect or intent of any of the foregoing being to mitigate loss to, or to manage risk or benefit of stock price changes for, such person, or any affiliates or associates of such person, or to increase or decrease the voting power or pecuniary or economic interest of such person, or any affiliates or associates of such person, with respect to stock of the Corporation; (iii) a description of all agreements, arrangements, or understandings (whether written or oral) between or among such person, or any affiliates or associates of such person, and any other person or persons (including their names) in connection with the proposal of such business and any material interest of such person or any affiliates or associates of such person, in such business, including any anticipated benefit therefrom to such person, or any affiliates or associates of such person; (iv) a representation (a) that the stockholder giving notice is a holder of record of stock of the Corporation entitled to vote at the Annual Meeting or Special Meeting and intends to appear in person or by proxy at the Annual Meeting to bring such business before the meeting and (b) whether the stockholder (and any beneficial owners on whose behalf the proposal is made) intends to continue to hold the shares through the date of the Annual Meeting or Special Meeting; (v) a representation whether the stockholder or any of the beneficial owners intends or is part of a group which intends (a) to deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation’s outstanding capital stock which, together with the holdings of such stockholder and all such beneficial owners, is sufficient to approve or adopt the proposal, and/or (b) otherwise to solicit proxies from stockholders in support of such proposal; and (vi) any other information relating to such person that would be required to be disclosed in a proxy statement or other filing required to be made in connection with the solicitation of proxies by such person with respect to the proposed business to be brought by such person before the Annual Meeting pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder. A stockholder providing notice of business proposed to be brought before an Annual Meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 2.15 shall be true and correct as of the record date for determining the stockholders entitled to receive notice of the Annual Meeting and such update and supplement shall be delivered to or be mailed and received by the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for determining the stockholders entitled to receive notice of the Annual Meeting. No business shall be conducted at the Annual Meeting of Stockholders except business brought before the Annual Meeting in accordance with the procedures set forth in this Section 2.15; provided, however, that, once business has been properly brought before the Annual Meeting in accordance with such procedures, nothing in this Section 2.15 shall be deemed to preclude discussion by any stockholder of any such business. If the chair of an Annual Meeting determines that business was not properly brought before the Annual Meeting in accordance with the foregoing procedures, the chair shall declare to the meeting that the business was not properly brought before the meeting and such business shall not be transacted. Notwithstanding the foregoing provisions of this Section 2.15, unless otherwise required by law or expressly waived in writing by the Corporation, if the stockholder (or a qualified 6


 
representative of the stockholder) does not appear at the Annual Meeting to present such proposed business, such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of this Section 2.15, to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the Annual Meeting and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the Annual Meeting. Nothing contained in this Section 2.15 shall be deemed to affect any rights of stockholders to request inclusion of proposals in the Corporation’s proxy statement pursuant to Rule 14a-8 under the Exchange Act (or any successor provision of law). Section 2.16 Nomination of Directors. Only persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the Corporation, except as may be otherwise provided in the Certificate of Incorporation with respect to the right, if any, of holders of preferred stock of the Corporation to nominate and elect a specified number of directors in certain circumstances. Nominations of persons for election to the Board of Directors may be made at any Annual Meeting of Stockholders or at any Special Meeting of Stockholders called for the purpose of electing directors (i) by or at the direction of the Board of Directors (or any duly authorized committee thereof) or (ii) by any stockholder of the Corporation (a) who is a stockholder of record on the date of the giving of the notice provided for in this Section 2.16 and on the record date for the determination of stockholders entitled to notice of and to vote at such Annual Meeting or Special Meeting, (b) who is entitled to vote at such Annual Meeting or Special Meeting and (c) who complies with the notice procedures set forth in this Section 2.16. Clause (ii) of the preceding sentence shall be the exclusive means for a stockholder to make nominations of persons for election to the Board of Directors. In addition to any other applicable requirements, for a nomination to be made by a stockholder, such stockholder must have given timely notice thereof in proper written form to the Secretary of the Corporation. To be timely, a stockholder’s notice to the Secretary must be delivered to or be mailed and received at the principal executive offices of the Corporation (a) in the case of an Annual Meeting, not later than the close of business on the ninetieth (90th) day nor earlier than the close of business on the one hundred and twentieth (120th) day prior to the anniversary date of the immediately preceding Annual Meeting of Stockholders; provided, however, that in the event that the Annual Meeting is called for a date that is not within thirty (30) days before or after such anniversary date, or in the case of the Corporation’s first Annual Meeting, notice by the stockholder in order to be timely must be so received not later than the close of business on the tenth (10th) day following the day on which such notice of the date of the Annual Meeting was mailed or such public disclosure of the date of the Annual Meeting was made, whichever first occurs; and (b) in the case of a Special Meeting of Stockholders called for the purpose of electing directors, not later than the close of business on the tenth (10th) day following the day on which notice of the date of the Special Meeting was mailed or public disclosure of the date of the Special Meeting was made, whichever first occurs. In no event shall the adjournment or postponement of an Annual Meeting or a Special Meeting called for the purpose of electing directors, or the public announcement of such an adjournment or 7


 
postponement, commence a new time period (or extend any time period) for the giving of a stockholder’s notice as described above. To be in proper written form, a stockholder’s notice to the Secretary must set forth the following information: (a) as to each person whom the stockholder proposes to nominate for election as a director (i) the name, age, business address and residence address of such person, (ii) the principal occupation or employment of such person, (iii) (A) the class or series and number of all shares of stock of the Corporation which are owned, directly or indirectly, beneficially or of record by such person and any affiliates or associates of such person, (B) the name of each nominee holder of shares of all stock of the Corporation owned beneficially but not of record by such person or any affiliates or associates of such person, and the number of such shares of stock of the Corporation held by each such nominee holder, (C) whether and the extent to which any derivative instrument, swap, option, warrant, short interest, hedge or profit interest or other transaction has been entered into by or on behalf of such person, or any affiliates or associates of such person, with respect to stock of the Corporation and (D) whether and the extent to which any other transaction, agreement, arrangement or understanding (including any short position or any borrowing or lending of shares of stock of the Corporation) has been made by or on behalf of such person, or any affiliates or associates of such person, the effect or intent of any of the foregoing being to mitigate loss to, or to manage risk or benefit of stock price changes for, such person, or any affiliates or associates of such person, or to increase or decrease the voting power or pecuniary or economic interest of such person, or any affiliates or associates of such person, with respect to stock of the Corporation; and (iv) any other information relating to such person that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Exchange Act, and the rules and regulations promulgated thereunder; and (b) as to the stockholder giving the notice, and the beneficial owner, if any, on whose behalf the nomination is being made, (i) the name and record address of the stockholder giving the notice and the name and principal place of business of such beneficial owner; (ii) (A) the class or series and number of all shares of stock of the Corporation which are owned beneficially or of record by such person and any affiliates or associates of such person, (B) the name of each nominee holder of shares of the Corporation owned beneficially but not of record by such person or any affiliates or associates of such person, and the number of shares of stock of the Corporation held by each such nominee holder, (C) whether and the extent to which any derivative instrument, swap, option, warrant, short interest, hedge or profit interest or other transaction has been entered into by or on behalf of such person, or any affiliates or associates of such person, with respect to stock of the Corporation and (D) whether and the extent to which any other transaction, agreement, arrangement or understanding (including any short position or any borrowing or lending of shares of stock of the Corporation) has been made by or on behalf of such person, or any affiliates or associates of such person, the effect or intent of any of the foregoing being to mitigate loss to, or to manage risk or benefit of stock price changes for, such person, or any affiliates or associates of such person, or to increase or decrease the voting power or pecuniary or economic interest of such person, or any affiliates or associates of such person, with respect to stock of the Corporation; (iii) a description of all agreements, arrangements, or understandings (whether written or oral) between or among such person, or any affiliates or associates of such person, and any proposed nominee or any other person or persons (including their names) pursuant to which the nomination(s) are being made by such person, and any material interest of such person, or any affiliates or associates of such person, in such nomination, including any 8


 
anticipated benefit therefrom to such person, or any affiliates or associates of such person; (iv) a representation (a) that the stockholder giving notice is a holder of record of stock of the Corporation entitled to vote at the Annual Meeting or Special Meeting and intends to appear in person or by proxy at the Annual Meeting or Special Meeting to nominate the persons named in its notice and (b) whether the stockholder (and any beneficial owners on whose behalf the nomination is made) intends to continue to hold the shares through the date of the Annual Meeting or Special Meeting; (v) a representation whether the stockholder or any of the beneficial owners intends or is part of a group which intends (a) to deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation’s outstanding capital stock which, together with the holdings of such stockholder and all such beneficial owners, is sufficient to elect the nominee, and/or (b) otherwise to solicit proxies from stockholders in support of such nomination; and (vi) any other information relating to such person that would be required to be disclosed in a proxy statement or other filings required to be made in connection with the solicitation of proxies for election of directors pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder. Such notice must be accompanied by a written consent of each proposed nominee to being named as a nominee and stating such nominee’s intention, if elected, to serve the full term of the class of directors for which such nominee is standing for election. The Corporation may require any proposed nominee to furnish such other information as the Corporation may reasonably require to determine the eligibility of such proposed nominee to serve as a director of the Corporation. A stockholder providing notice of any nomination proposed to be made at an Annual Meeting or Special Meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 2.16 shall be true and correct as of the record date for determining the stockholders entitled to receive notice of the Annual Meeting or Special Meeting, and such update and supplement shall be delivered to or be mailed and received by the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for determining the stockholders entitled to receive notice of such Annual Meeting or Special Meeting. No person shall be eligible for election as a director of the Corporation unless nominated in accordance with the procedures set forth in this Section 2.16. If the chair of the meeting determines that a nomination was not made in accordance with the foregoing procedures, the chair shall declare to the meeting that the nomination was defective, and such defective nomination shall be disregarded. Notwithstanding the foregoing provisions of this Section 2.16, unless otherwise required by law or expressly waived in writing by the Corporation, if the stockholder (or a qualified representative of the stockholder) does not appear at the Annual Meeting or Special Meeting to present such nomination, such nomination shall be disregarded, notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of this Section 2.16, to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the Annual Meeting or Special Meeting and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the Annual Meeting or Special Meeting. 9


 
ARTICLE III DIRECTORS Section 3.1 Number and Election of Directors. The Board of Directors shall consist of not less than three (3) nor more than fifteen (15) members, the exact number of which shall be fixed from time to time exclusively pursuant to a resolution adopted by the affirmative vote of a majority of the entire Board of Directors, and subject to the rights of the holders of the preferred stock, if any, the exact number may be increased or decreased (but not to less than three (3) or more than fifteen (15)). Except as provided in Section 3.2, directors shall be elected by a majority of the votes cast at the annual meeting of stockholders; provided, however, that, if the number of nominees for director exceeds the number of directors to be elected, directors shall be elected by a plurality of the votes cast. A director shall hold office until the Annual Meeting for the year in which his or her term expires and until his or her successor shall be elected and shall qualify, subject, however, to prior death, resignation, retirement, disqualification or removal from office. Directors need not be stockholders. The directors shall, until the Annual Meeting of Stockholders to be held in 2021, be divided into three classes, designated Class I, Class II and Class III. Each class shall consist, as nearly as may be possible, of an equal number of directors. The term of the Class I directors shall terminate on the date of the 2020 Annual Meeting of Stockholders; the term of the Class II directors elected at the 2018 Annual Meeting of Stockholders shall terminate on the date of the 2021 Annual Meeting of Stockholders; and the term of the Class III directors shall terminate on the date of the 2019 Annual Meeting of Stockholders or, in each case, upon such director’s earlier death, resignation or removal. At each succeeding Annual Meeting of Stockholders beginning with the 2019 Annual Meeting of Stockholders, directors standing for election shall be elected annually for one-year terms expiring at the next succeeding Annual Meeting of Stockholders and until his or her respective successor has been duly elected and qualified. Section 3.2 Vacancies. Subject to the terms of any one or more classes or series of preferred stock, any vacancy on the Board of Directors that results from an increase in the number of directors or the death, resignation, retirement, disqualification, removal from office or other cause may be filled by a majority of the Board of Directors then in office, in their sole discretion, even if less than a quorum, or by a sole remaining director, in his or her sole discretion. Any director appointed to fill a vacancy on the Corporation’s Board of Directors not resulting from an increase in the number of directors shall have the same remaining term as that of his or her predecessor. In no case will a decrease in the number of directors have the effect of removing or shortening the term of any incumbent director. Section 3.3 Duties and Powers. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors which may exercise all such powers of the Corporation and do all such lawful acts and things as are not by statute or by the Certificate of Incorporation or by these By-Laws required to be exercised or done by the stockholders. Section 3.4 Meetings; Notice. The Board of Directors and any committee thereof may hold meetings, both regular and special, either within or without the State of Delaware. Regular 10


 
meetings of the Board of Directors or any committee thereof may be held without notice at such time and at such place as may from time to time be determined by the Board of Directors or such committee, respectively. Special meetings of the Board of Directors may be called by the Chairman of the Board, the Chief Executive Officer or a majority of the members of the Board of Directors. Special meetings of any committee of the Board of Directors may be called by the chair of such committee, the Chief Executive Officer, or any director serving on such committee. Notice of all meetings shall state the place, date and hour of the meeting and shall be given to each director (or, in the case of a committee, to each member of such committee) either by mail not less than seven (7) days before the date of the meeting, by facsimile or other means of electronic communication on three (3) days’ notice, by personal delivery or telephone on twenty- four (24) hours’ notice, or on such shorter notice as the person or persons calling such meeting may deem necessary or appropriate in the circumstances. Any director may waive notice of any meeting before or after the meeting. The attendance of a director at any meeting shall constitute a waiver of notice of such meeting, except where the director attends the meeting for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the Board of Directors need be specified in any notice or waiver of notice of such meeting unless so required by law. Section 3.5 Organization. At each meeting of the Board of Directors or any committee thereof, the Chairman of the Board of Directors or the chair of such committee, as the case may be, or, in his or her absence, a director chosen by a majority of the directors present, shall act as chair. Except as provided below, the Secretary of the Corporation shall act as secretary at each meeting of the Board of Directors and of each committee thereof. In case the Secretary shall be absent from any meeting of the Board of Directors or of any committee thereof, an Assistant Secretary shall perform the duties of secretary at such meeting; and in the absence from any such meeting of the Secretary and all the Assistant Secretaries, the chair of the meeting may appoint any person to act as secretary of the meeting. Notwithstanding the foregoing, the members of each committee of the Board of Directors may appoint any person to act as secretary of any meeting of such committee and the Secretary or any Assistant Secretary of the Corporation may, but need not if such committee so elects, serve in such capacity. Section 3.6 Resignations and Removals of Directors. Any director of the Corporation may resign from the Board of Directors or any committee thereof at any time, by giving notice in writing or by electronic transmission to the Chairman of the Board of Directors, the Chief Executive Officer or the Secretary of the Corporation and, in the case of a committee, to the chair of such committee. Such resignation shall take effect at the time therein specified or, if no time is specified, immediately; and, unless otherwise specified in such notice, the acceptance of such resignation shall not be necessary to make it effective. Prior to and until the time at which the Board of Directors ceases to be classified pursuant to Section 3.1 of these By-Laws, except as otherwise required by applicable law and subject to the rights, if any, of the holders of shares of preferred stock then outstanding, any director or the entire Board of Directors may be removed from office at any time, but only for cause and only by the affirmative vote of the holders of at least a majority of the shares of voting common stock. From and after the time at which the Board of Directors ceases to be classified pursuant to Section 3.1, except as otherwise required by applicable law and subject to the rights, if any, of 11


 
the holders of shares of preferred stock then outstanding, any or all of the directors of the Corporation may be removed from office at any time, with or without cause, by the affirmative vote of the holders of at least a majority of shares of voting common stock. Any director serving on a committee of the Board of Directors may be removed from such committee at any time by the Board of Directors. Section 3.7 Quorum. Except as otherwise required by law, the Certificate of Incorporation or these By-Laws, at all meetings of the Board of Directors or any committee thereof, a one third (1/3rd) of the entire Board of Directors, but not less than three (3), or one third (1/3rd) of the directors constituting such committee, but not less than two (2), as the case may be, shall constitute a quorum for the transaction of business and the act of a majority of the directors or committee members present at any meeting at which there is a quorum shall be the act of the Board of Directors or such committee, as applicable. If a quorum shall not be present at any meeting of the Board of Directors or any committee thereof, the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting of the time and place of the adjourned meeting, until a quorum shall be present. Section 3.8 Actions of the Board by Written Consent. Unless otherwise provided in the Certificate of Incorporation or these By-Laws, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all the members of the Board of Directors or such committee, as the case may be, consent thereto in writing or by electronic transmission, and the writing or writings or electronic transmission are filed with the minutes of proceedings of the Board of Directors or such committee. Section 3.9 Meetings by Means of Conference Telephone. Unless otherwise provided in the Certificate of Incorporation or these By-Laws, members of the Board of Directors, or any committee thereof, may participate in a meeting of the Board of Directors or such committee by means of a conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this Section 3.9 shall constitute presence in person at such meeting. Section 3.10 Committees. The Board of Directors shall have, at all times, the following standing committees: an Audit Committee, a Compensation Committee and a Governance and Nominating Committee. Each of the Audit Committee, the Compensation Committee and the Governance and Nominating Committee will consist of at least three members. The Board of Directors may designate one or more other standing or special committees, each such committee to consist of one or more of the directors of the Corporation. The Board of Directors will appoint committee members of each standing committee and the chair of each such committee on the recommendation of the Governance and Nominating Committee. Each member of a committee must meet the requirements for membership, if any, imposed by applicable law and the rules and regulations of any securities exchange or quotation system on which the securities of the Corporation are listed or quoted for trading. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of any such committee. Subject to the rules and regulations of any securities exchange or quotation system on which the securities of the Corporation are listed or quoted for trading, in the absence or disqualification of a member of a committee, and in 12


 
the absence of a designation by the Board of Directors of an alternate member to replace the absent or disqualified member, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another qualified member of the Board of Directors to act at the meeting in the place of any absent or disqualified member. Any committee, to the extent permitted by law and provided in its charter or as may be assigned to it by the Board of Directors, shall have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it. Each committee shall keep regular minutes and report to the Board of Directors when required. Notwithstanding anything to the contrary contained in this Article III, any resolution of the Board of Directors establishing or directing any committee of the Board of Directors or establishing or amending the charter of any such committee may establish requirements or procedures relating to the governance and/or operation of such committee that are different from, or in addition to, those set forth in these By-Laws and, to the extent that there is any inconsistency between these By-Laws and any such resolution or charter, the terms of such resolution or charter shall be controlling. Section 3.11 Executive Committee. The Board of Directors may provide for an executive committee of two or more directors and shall elect the members thereof to serve during the pleasure of the Board of Directors. The Board of Directors may designate one of such members to act as chair, provided that the Chairman of the Board shall be a member of the Executive Committee and, if present, shall preside at any meeting of the Executive Committee. The Board of Directors shall have the power at any time to change the membership of the committee, to fill vacancies in it, or to dissolve it. During the intervals between the meetings of the Board of Directors, the Executive Committee shall possess and may exercise any or all of the powers of the Board of Directors in the management of the business and affairs of the Corporation to the extent authorized by resolution adopted by a majority of the entire Board of Directors. The Executive Committee may determine its rules of procedure and the notice to be given of its meetings, and it may appoint such committees and assistants as it shall from time to time deem necessary. A majority of the members of the committee shall constitute a quorum. Section 3.12 Compensation. The Board of Directors, upon the recommendation of the Compensation Committee, shall from time to time determine the form and amount of fees or compensation to be paid to the directors for services as such to the Corporation, including, but not limited to, fees and expenses for serving on and/or attendance at meetings of the Board of Directors or its committees. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor. Section 3.13 Interested Directors. No contract or transaction between the Corporation (or any of its subsidiaries or affiliates) and one or more of its directors or officers, or between the Corporation (or any of its subsidiaries or affiliates) and any other corporation, partnership, association or other organization in which one or more of its directors or officers are directors or officers or have a financial interest, shall be void or voidable solely for this reason, or solely because the director or officer is present at or participates in the meeting of the Board of Directors or committee thereof which authorizes the contract or transaction, or solely because 13


 
any such director’s or officer’s vote is counted for such purpose if: (i) the material facts as to the director’s or officer’s relationship or interest and as to the contract or transaction are disclosed or are known to the Board of Directors or the committee, and the Board of Directors or committee in good faith authorizes the contract or transaction by the affirmative vote of a majority of the disinterested directors, even though the disinterested directors be less than a quorum; or (ii) the material facts as to the director’s or officer’s relationship or interest and as to the contract or transaction are disclosed or are known to the stockholders entitled to vote thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders; or (iii) the contract or transaction is fair as to the Corporation as of the time it is authorized, approved or ratified by the Board of Directors, a committee thereof or the stockholders. Common or interested directors may be counted in determining the presence of a quorum at a meeting of the Board of Directors or of a committee which authorizes the contract or transaction. ARTICLE IV OFFICERS Section 4.1 General. The officers of the Corporation shall be chosen by the Board of Directors and shall be a Chief Executive Officer, a Secretary and a Treasurer. The Board of Directors, in its discretion, also may choose a President, one or more Vice Presidents, Assistant Secretaries, Assistant Treasurers and other officers. Any number of offices may be held by the same person, unless otherwise prohibited by law, the Certificate of Incorporation or these By- Laws. The officers of the Corporation need not be stockholders of the Corporation. Section 4.2 Election. The Board of Directors, at its first meeting held after each Annual Meeting of Stockholders, shall elect the officers of the Corporation who shall hold their offices for such terms and shall exercise such powers and perform such duties as shall be determined from time to time by the Board of Directors; and each officer of the Corporation shall hold office until such officer’s successor is elected and qualified, or until such officer’s earlier death, resignation or removal. Any officer elected by the Board of Directors may be removed at any time by the Board of Directors. Any vacancy occurring in any office of the Corporation shall be filled by the Board of Directors. The salaries of all officers of the Corporation shall be fixed by the Board of Directors. Any officer may resign at any time by delivering a notice of resignation given in writing or electronic transmission to the Board of Directors or the Chief Executive Officer or the Secretary. Unless otherwise specified therein, such resignation shall take effect upon delivery. Section 4.3 Voting Securities Owned by the Corporation. Powers of attorney, proxies, waivers of notice of meeting, consents and other instruments relating to securities owned by the Corporation may be executed in the name of and on behalf of the Corporation by the Chief Executive Officer, any President, any Vice President or any other officer authorized to do so by the Board of Directors and any such officer may, in the name of and on behalf of the Corporation, take all such action as any such officer may deem advisable to vote in person or by proxy at any meeting of security holders of any corporation in which the Corporation may own securities and at any such meeting shall possess and may exercise any and all rights and power incident to the ownership of such securities and which, as the owner thereof, the Corporation 14


 
might have exercised and possessed if present. The Board of Directors may, by resolution, from time to time confer like powers upon any other person or persons. Section 4.4 Chairman of the Board of Directors. The Board of Directors, in its discretion, may choose a Chairman (who shall be a director but need not be elected as an officer). The Chairman of the Board of Directors shall preside at all meetings of the stockholders, the Board of Directors and the Executive Committee (if one shall have been appointed). The Chairman of the Board of Directors shall perform such other duties and may exercise such other powers as may from time to time be assigned by these By-Laws or by the Board of Directors. Section 4.5 Chief Executive Officer. The Chief Executive Officer shall, subject to the control of the Board of Directors and the Chairman of the Board of Directors, have general supervision of the business of the Corporation and shall see that all orders and resolutions of the Board of Directors are carried into effect. The Chief Executive Officer shall execute all bonds, mortgages, contracts and other instruments of the Corporation requiring a seal, under the seal of the Corporation, except where required or permitted by law to be otherwise signed and executed and except as provided by Section 7.5. In the absence or disability of the Chairman of the Board of Directors, the Chief Executive Officer shall preside at all meetings of the stockholders. The Chief Executive Officer shall also perform such other duties and may exercise such other powers as may from time to time be assigned to such officer by these By-Laws or by the Board of Directors. Section 4.6 Vice Presidents. Each Vice President shall have such powers and shall perform such duties as shall be assigned to him by the Board of Directors. Section 4.7 Secretary. The Secretary shall attend all meetings of the Board of Directors and all meetings of the stockholders and record all the proceedings thereat in a book or books to be kept for that purpose; the Secretary shall also perform like duties for committees of the Board of Directors when required. The Secretary shall give, or cause to be given, notice of all meetings of the stockholders and special meetings of the Board of Directors, and shall perform such other duties as may be prescribed by the Board of Directors, the Chairman of the Board of Directors or the Chief Executive Officer, under whose supervision the Secretary shall be. If the Secretary shall be unable or shall refuse to cause to be given notice of all meetings of the stockholders and special meetings of the Board of Directors, and if there be no Assistant Secretary, then either the Board of Directors or the Chief Executive Officer may choose another officer to cause such notice to be given. The Secretary shall have custody of the seal of the Corporation and the Secretary or any Assistant Secretary, if there be one, shall have authority to affix the same to any instrument requiring it and when so affixed, it may be attested by the signature of the Secretary or by the signature of any such Assistant Secretary. The Board of Directors may give general authority to any other officer to affix the seal of the Corporation and to attest to the affixing by such officer’s signature. The Secretary shall see that all books, reports, statements, certificates and other documents and records required by law to be kept or filed are properly kept or filed, as the case may be. Section 4.8 Treasurer. The Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts of receipts and disbursements in books 15


 
belonging to the Corporation and shall deposit all moneys and other valuable effects in the name and to the credit of the Corporation in such depositories as may be designated by the Board of Directors. The Treasurer shall disburse the funds of the Corporation as may be ordered by the Board of Directors, taking proper vouchers for such disbursements, and shall render to the Chief Executive Officer and the Board of Directors, at its regular meetings, or when the Board of Directors so requires, an account of all transactions as Treasurer and of the financial condition of the Corporation. If required by the Board of Directors, the Treasurer shall give the Corporation a bond in such sum and with such surety or sureties as shall be satisfactory to the Board of Directors for the faithful performance of the duties of the office of the Treasurer and for the restoration to the Corporation, in case of the Treasurer’s death, resignation, retirement or removal from office, of all books, papers, vouchers, money and other property of whatever kind in the Treasurer’s possession or under the Treasurer’s control belonging to the Corporation. Section 4.9 Assistant Secretaries. Assistant Secretaries, if there be any, shall perform such duties and have such powers as from time to time may be assigned to them by the Board of Directors, the Chief Executive Officer, any Vice President, if there be one, or the Secretary, and in the absence of the Secretary or in the event of the Secretary’s inability or refusal to act, shall perform the duties of the Secretary, and when so acting, shall have all the powers of and be subject to all the restrictions upon the Secretary. Section 4.10 Assistant Treasurers. Assistant Treasurers, if there be any, shall perform such duties and have such powers as from time to time may be assigned to them by the Board of Directors, the Chief Executive Officer, any Vice President, if there be one, or the Treasurer, and in the absence of the Treasurer or in the event of the Treasurer’s inability or refusal to act, shall perform the duties of the Treasurer, and when so acting, shall have all the powers of and be subject to all the restrictions upon the Treasurer. If required by the Board of Directors, an Assistant Treasurer shall give the Corporation a bond in such sum and with such surety or sureties as shall be satisfactory to the Board of Directors for the faithful performance of the duties of the office of Assistant Treasurer and for the restoration to the Corporation, in case of the Assistant Treasurer’s death, resignation, retirement or removal from office, of all books, papers, vouchers, money and other property of whatever kind in the Assistant Treasurer’s possession or under the Assistant Treasurer’s control belonging to the Corporation. Section 4.11 Other Officers. Such other officers as the Board of Directors may choose shall perform such duties and have such powers as from time to time may be assigned to them by the Board of Directors. The Board of Directors may delegate to any other officer of the Corporation the power to choose such other officers and to prescribe their respective duties and powers. ARTICLE V STOCK Section 5.1 Uncertificated Shares. Unless otherwise provided by resolution of the Board of Directors, each class or series of the shares of capital stock in the Corporation shall be issued in uncertificated form pursuant to the customary arrangements for issuing shares in such form. Shares shall be transferable only on the books of the Corporation by the holder thereof in 16


 
person or by attorney upon presentment of proper evidence of succession, assignation or authority to transfer in accordance with the customary procedures for transferring shares in uncertificated form. Section 5.2 Dividend Record Date. In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than sixty (60) days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto. Section 5.3 Record Owners. The Corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends, and to vote as such owner, and to hold liable for calls and assessments a person registered on its books as the owner of shares, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise required by law. Section 5.4 Transfer and Registry Agents. The Corporation may from time to time maintain one or more transfer offices or agencies and registry offices or agencies at such place or places as may be determined from time to time by the Board of Directors. ARTICLE VI NOTICES Section 6.1 Notices. Whenever written notice is required by law, the Certificate of Incorporation or these By-Laws, to be given to any director, member of a committee or stockholder, such notice may be given either personally by mail, facsimile or other means of electronic communication or by other lawful means. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail addressed to such director, member of a committee or stockholder, at such person’s address as it appears on the records of the Corporation, with postage thereon prepaid. If notice be by facsimile or other means of electronic communication, such notice shall be deemed to be given at the time provided in the DGCL. Such further notice shall be given as may be required by law. Section 6.2 Waivers of Notice. Whenever any notice is required by applicable law, the Certificate of Incorporation or these By-Laws, to be given to any director, member of a committee or stockholder, a waiver thereof in writing, signed by the person or persons entitled to notice, whether before or after the time stated therein, shall be deemed equivalent thereto. Attendance of a person at a meeting, present in person or represented by proxy, shall constitute a waiver of notice of such meeting, except where the person attends the meeting for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the 17


 
purpose of, any Annual or Special Meeting of Stockholders or any regular or special meeting of the directors or members of a committee of directors need be specified in any written waiver of notice unless so required by law, the Certificate of Incorporation or these By-Laws. ARTICLE VII GENERAL PROVISIONS Section 7.1 Dividends. Dividends upon the capital stock of the Corporation, subject to the requirements of the DGCL and the provisions of the Certificate of Incorporation, if any, may be declared by the Board of Directors at any regular or special meeting of the Board of Directors (or any action by written consent in lieu thereof in accordance with Section 3.8), and may be paid in cash, in property, or in shares of the Corporation’s capital stock. Before payment of any dividend, there may be set aside out of any funds of the Corporation available for dividends such sum or sums as the Board of Directors from time to time, in its absolute discretion, deems proper as a reserve or reserves to meet contingencies, or for purchasing any of the shares of capital stock, warrants, rights, options, bonds, debentures, notes, scrip or other securities or evidences of indebtedness of the Corporation, or for equalizing dividends, or for repairing or maintaining any property of the Corporation, or for any proper purpose, and the Board of Directors may modify or abolish any such reserve. Section 7.2 Disbursements. All checks or demands for money and notes of the Corporation shall be signed by such officer or officers or such other person or persons as the Board of Directors may from time to time designate. Section 7.3 Fiscal Year. Unless otherwise fixed by resolution of the Board of Directors, the fiscal year of the Corporation shall end on December 31. Section 7.4 Corporate Seal. The corporate seal shall have inscribed thereon the name of the Corporation, the year of its organization and the words “Corporate Seal, Delaware”. The seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise. Section 7.5 Contracts. These By-Laws, the Board of Directors or the Chief Executive Officer may authorize any officer or officers or any agent or agents to enter into any contract or execute and deliver any instrument or other document in the name of and on behalf of the Corporation, and such authority may be general or confined to specific instances. ARTICLE VIII INDEMNIFICATION Section 8.1 Power to Indemnify in Actions, Suits or Proceedings other than Those by or in the Right of the Corporation. Subject to Section 8.3, the Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation), by reason of the fact that such person is or was a director or officer of the Corporation, or is or was a director, officer or employee of 18


 
the Corporation serving at the request of the Corporation as a director, officer, employee or agent of, or in a fiduciary capacity with respect to, another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person’s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that such person’s conduct was unlawful. Section 8.2 Power to Indemnify in Actions, Suits or Proceedings by or in the Right of the Corporation. Subject to Section 8.3, the Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that such person is or was a director or officer of the Corporation, or is or was a director, officer or employee of the Corporation serving at the request of the Corporation as a director, officer, employee or agent of, or in a fiduciary capacity with respect to, another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation; except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery of the State of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. Section 8.3 Authorization of Indemnification. Any indemnification under this Article VIII (unless ordered by a court) shall be made by the Corporation only as authorized in the specific case upon a determination that indemnification of the present or former director, officer or employee is proper in the circumstances because such person has met the applicable standard of conduct set forth in Section 8.1 or Section 8.2, as the case may be. Such determination shall be made, with respect to a person who is a director, officer or employee at the time of such determination, (i) by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, or (ii) by a committee of such directors designated by a majority vote of such directors, even though less than a quorum, or (iii) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion or (iv) by the stockholders. Such determination shall be made, with respect to present or former employees or former directors and officers, by any person or persons having the authority to act on the matter on behalf of the Corporation. To the extent, however, that a present or former director, officer or employee of the Corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding described above, or in defense of any claim, issue or 19


 
matter therein, such person shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection therewith, without the necessity of authorization in the specific case. Section 8.4 Good Faith Defined. For purposes of any determination under Section 8.3 of this Article VIII, a person shall be deemed to have acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation, or, with respect to any criminal action or proceeding, to have had no reasonable cause to believe such person’s conduct was unlawful, if such person’s action is based on the records or books of account of the Corporation or another enterprise, or on information supplied to such person by the officers of the Corporation or another enterprise in the course of their duties, or on the advice of legal counsel for the Corporation or another enterprise or on information or records given or reports made to the Corporation or another enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Corporation or another enterprise. The provisions of this Section 8.4 shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable standard of conduct set forth in Section 8.1 or Section 8.2, as the case may be. Section 8.5 Indemnification by a Court. Notwithstanding any contrary determination in the specific case under Section 8.3, and notwithstanding the absence of any determination thereunder, any director, officer or employee may apply to the Court of Chancery of the State of Delaware or any other court of competent jurisdiction in the State of Delaware for indemnification to the extent otherwise permissible under Section 8.1 or Section 8.2. The basis of such indemnification by a court shall be a determination by such court that indemnification of the director, officer or employee is proper in the circumstances because such person has met the applicable standard of conduct set forth in Section 8.1 or Section 8.2, as the case may be. Neither a contrary determination in the specific case under Section 8.3 nor the absence of any determination thereunder shall be a defense to such application or create a presumption that the director, officer or employee seeking indemnification has not met any applicable standard of conduct. Notice of any application for indemnification pursuant to this Section 8.5 shall be given to the Corporation promptly upon the filing of such application. If successful, in whole or in part, the director, officer or employee seeking indemnification shall also be entitled to be paid the expense of prosecuting such application. Section 8.6 Expenses Payable in Advance. Expenses (including attorneys’ fees) incurred by a current or former director or officer or employee entitled to indemnification under this Article VIII in defending any civil, criminal, administrative or investigative action, suit or proceeding shall be paid by the Corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such current or former director, officer or employee to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the Corporation as authorized in this Article VIII. Section 8.7 Nonexclusivity of Indemnification and Advancement of Expenses. The indemnification and advancement of expenses provided by, or granted pursuant to, this Article VIII shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under the Certificate of Incorporation, these By-Laws, any statute, agreement, vote of stockholders or disinterested directors or otherwise, both as to 20


 
action in such person’s official capacity and as to action in another capacity while holding such office, it being the policy of the Corporation that indemnification of the persons specified in Section 8.1 and Section 8.2 shall be made to the fullest extent permitted by law. The provisions of this Article VIII shall not be deemed to preclude the indemnification of any person who is not specified in Section 8.1 or Section 8.2 but whom the Corporation has the power or obligation to indemnify under the provisions of the DGCL, or otherwise. Section 8.8 Insurance. The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer or employee of the Corporation, or is or was a director or officer of the Corporation serving at the request of the Corporation as a director, officer, employee or agent of, or in a fiduciary capacity with respect to, another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the Corporation would have the power or the obligation to indemnify such person against such liability under the provisions of this Article VIII. Section 8.9 Certain Definitions. For purposes of this Article VIII, references to “the Corporation” shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors or officers, so that any person who is or was a director or officer of such constituent corporation, or is or was a director or officer of such constituent corporation or is or was a director, officer or employee of such constituent corporation serving at the request of such constituent corporation as a director, officer, employee or agent of, or in a fiduciary capacity with respect to, another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under the provisions of this Article VIII with respect to the resulting or surviving corporation as such person would have with respect to such constituent corporation if its separate existence had continued. The term “another enterprise” as used in this Article VIII shall mean any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise of which such person is or was serving at the request of the Corporation as a director, officer, employee, fiduciary or agent. For purposes of this Article VIII, references to “fines” shall include any excise taxes assessed on a person with respect to an employee benefit plan; and references to “serving at the request of the Corporation” shall include any service as a director, officer, employee or agent of, or fiduciary with respect to, another enterprise which imposes duties on, or involves services by, such director, officer or employee with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the Corporation” as referred to in this Article VIII. Section 8.10 Survival of Indemnification and Advancement of Expenses. The indemnification and advancement of expenses provided by, or granted pursuant to, this Article VIII shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer or employee and shall inure to the benefit of the heirs, executors and administrators of such a person. 21


 
Section 8.11 Limitation on Indemnification. Notwithstanding anything contained in this Article VIII to the contrary, except for proceedings to enforce rights to indemnification (which shall be governed by Section 8.5), the Corporation shall not be obligated to indemnify any person entitled to indemnification under this Article VIII (or his or her heirs, executors or personal or legal representatives) or advance expenses in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized or consented to by the Board of Directors of the Corporation. Section 8.12 Indemnification of Employees and Agents. The Corporation may, to the extent authorized from time to time by the Board of Directors, provide rights to indemnification and to the advancement of expenses to other employees and agents of the Corporation similar to those conferred in this Article VIII to directors and officers of the Corporation. Section 8.13 Amendment or Repeal. Any repeal or modification of the foregoing provisions of this Article XIII shall not adversely affect any right or protection hereunder of a director, officer or employee of the Corporation in respect of any proceeding (regardless of when such proceeding is first threatened, commenced or completed) arising out of, or related to, any act or omission occurring prior to the time of such repeal or modification. ARTICLE IX AMENDMENTS Section 9.1 Amendments. In furtherance and not in limitation of the powers conferred upon it by the laws of the State of Delaware, the Board of Directors shall have the power to adopt, amend, alter or repeal these By-Laws. The affirmative vote of at least a majority of the Board of Directors shall be required to adopt, amend, alter or repeal these By-Laws. In addition, these By-Laws may be altered, amended or repealed, in whole or in part, or new By-Laws may be adopted by the stockholders with the affirmative vote of the holders of at least a majority of the total number of votes of the Corporation’s capital stock then outstanding; provided, however, that notice of such alteration, amendment, repeal or adoption of new By-Laws by the stockholder be contained in the notice of such meeting of the stockholders. ARTICLE X CONSTRUCTION Section 10.1 Construction. In the event of any conflict between the provisions of these By-Laws as in effect from time to time and the provisions of the Certificate of Incorporation as in effect from time to time, the provisions of the Certificate of Incorporation shall be controlling. Section 10.2 Entire Board of Directors. As used in this Article IX and in these By- Laws generally, the term “entire Board of Directors” means the total number of directors which the Corporation would have if there were no vacancies and each other reference to the “Board of Directors” means the total number of directors then in office. * * * 22


 


Exhibit 31.1
CERTIFICATION PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934
I, Jeffrey S. Niew, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Knowles Corporation;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 30, 2019

 
 
/s/ JEFFREY S. NIEW
 
 
Name: Jeffrey S. Niew
 
 
Title: President and Chief Executive Officer
 
 
(Principal Executive Officer)





Exhibit 31.2
CERTIFICATION PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934
I, John S. Anderson, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of Knowles Corporation;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 30, 2019

 
 
/s/ JOHN S. ANDERSON
 
 
Name: John S. Anderson
 
 
Title: Senior Vice President & Chief Financial Officer
 
 
(Principal Financial Officer)





Exhibit 32.1
JOINT CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Knowles Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Jeffrey S. Niew and John S. Anderson, the Principal Executive and Financial Officers of the Company, certify, pursuant to and for purposes of 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


 
 
/s/ JEFFREY S. NIEW
 
 
Name: Jeffrey S. Niew
 
 
Title: President and Chief Executive Officer
 
 
(Principal Executive Officer)
 
 
Date: July 30, 2019
 
 
 
 
 
/s/ JOHN S. ANDERSON
 
 
Name: John S. Anderson
 
 
Title: Senior Vice President & Chief Financial Officer
 
 
(Principal Financial Officer)
 
 
Date: July 30, 2019